Gene Symbol | Gene ID | Gene Info |
---|---|---|
ZNF711
|
ENSG00000147180.12 | zinc finger protein 711 |
TFAP2A
|
ENSG00000137203.6 | transcription factor AP-2 alpha |
TFAP2D
|
ENSG00000008197.4 | transcription factor AP-2 delta |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr6_10412096_10412574 | TFAP2A | 272 | 0.897679 | 0.85 | 3.8e-03 | Click! |
chr6_10399107_10399258 | TFAP2A | 5645 | 0.203615 | 0.80 | 1.0e-02 | Click! |
chr6_10412868_10413115 | TFAP2A | 121 | 0.952705 | 0.75 | 1.9e-02 | Click! |
chr6_10415425_10415576 | TFAP2A | 19 | 0.934692 | -0.69 | 4.0e-02 | Click! |
chr6_10404110_10404446 | TFAP2A | 549 | 0.760953 | 0.61 | 8.3e-02 | Click! |
chr6_50680636_50680787 | TFAP2D | 830 | 0.765684 | 0.20 | 6.0e-01 | Click! |
chr6_50378521_50378672 | TFAP2D | 302945 | 0.012272 | -0.07 | 8.6e-01 | Click! |
chr6_50383487_50383638 | TFAP2D | 297979 | 0.012679 | 0.03 | 9.5e-01 | Click! |
chrX_84499187_84500398 | ZNF711 | 21 | 0.941167 | 0.34 | 3.7e-01 | Click! |
chrX_84498834_84499090 | ZNF711 | 35 | 0.632213 | 0.16 | 6.9e-01 | Click! |
chrX_84498582_84498733 | ZNF711 | 340 | 0.585159 | -0.14 | 7.2e-01 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr17_76123581_76124282 | 8.35 |
TMC6 |
transmembrane channel-like 6 |
780 |
0.49 |
chr2_162101279_162101855 | 7.74 |
AC009299.2 |
|
6106 |
0.21 |
chr12_124018329_124018683 | 7.08 |
RILPL1 |
Rab interacting lysosomal protein-like 1 |
241 |
0.89 |
chr1_26872331_26872899 | 6.69 |
RPS6KA1 |
ribosomal protein S6 kinase, 90kDa, polypeptide 1 |
272 |
0.88 |
chr9_134150778_134151758 | 6.44 |
FAM78A |
family with sequence similarity 78, member A |
666 |
0.69 |
chr1_26437710_26438043 | 6.39 |
PDIK1L |
PDLIM1 interacting kinase 1 like |
212 |
0.9 |
chr16_67063172_67063793 | 6.36 |
CBFB |
core-binding factor, beta subunit |
118 |
0.94 |
chr2_113190375_113190911 | 6.33 |
RGPD8 |
RANBP2-like and GRIP domain containing 8 |
453 |
0.86 |
chr17_80416602_80417044 | 6.11 |
NARF |
nuclear prelamin A recognition factor |
72 |
0.83 |
chr8_21777326_21777532 | 5.84 |
XPO7 |
exportin 7 |
161 |
0.95 |
chr2_136633640_136633978 | 5.70 |
MCM6 |
minichromosome maintenance complex component 6 |
187 |
0.95 |
chr11_67171589_67172183 | 5.63 |
TBC1D10C |
TBC1 domain family, member 10C |
226 |
0.8 |
chr11_62554197_62554732 | 5.57 |
RP11-727F15.12 |
|
207 |
0.63 |
chr9_134152676_134153362 | 5.57 |
FAM78A |
family with sequence similarity 78, member A |
1085 |
0.5 |
chr9_100745668_100746275 | 5.56 |
ANP32B |
acidic (leucine-rich) nuclear phosphoprotein 32 family, member B |
328 |
0.85 |
chr20_50158730_50159057 | 5.48 |
NFATC2 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 2 |
365 |
0.92 |
chr1_55266396_55266946 | 5.47 |
TTC22 |
tetratricopeptide repeat domain 22 |
200 |
0.91 |
chr9_129484934_129485155 | 5.46 |
ENSG00000266403 |
. |
4432 |
0.26 |
chr22_50050359_50050996 | 5.45 |
C22orf34 |
chromosome 22 open reading frame 34 |
401 |
0.87 |
chr17_56408975_56409725 | 5.43 |
MIR142 |
microRNA 142 |
519 |
0.63 |
chr6_33756412_33756901 | 5.37 |
LEMD2 |
LEM domain containing 2 |
49 |
0.97 |
chr19_796345_796959 | 5.29 |
PTBP1 |
polypyrimidine tract binding protein 1 |
423 |
0.68 |
chr19_8274217_8274814 | 5.29 |
CERS4 |
ceramide synthase 4 |
3 |
0.97 |
chr18_9614776_9615146 | 5.27 |
PPP4R1 |
protein phosphatase 4, regulatory subunit 1 |
68 |
0.97 |
chr15_43028751_43029277 | 5.26 |
CDAN1 |
codanin 1 |
238 |
0.94 |
chr9_140008700_140009150 | 5.24 |
DPP7 |
dipeptidyl-peptidase 7 |
231 |
0.78 |
chr2_134877876_134878476 | 5.23 |
MGAT5 |
mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase |
423 |
0.87 |
chr22_50913109_50913431 | 5.20 |
SBF1 |
SET binding factor 1 |
101 |
0.92 |
chr1_6674280_6674659 | 5.19 |
KLHL21 |
kelch-like family member 21 |
151 |
0.86 |
chr1_206680885_206681199 | 5.00 |
RASSF5 |
Ras association (RalGDS/AF-6) domain family member 5 |
163 |
0.93 |
chr19_3179462_3180177 | 5.00 |
S1PR4 |
sphingosine-1-phosphate receptor 4 |
1083 |
0.38 |
chrX_19905153_19905596 | 4.97 |
SH3KBP1 |
SH3-domain kinase binding protein 1 |
203 |
0.96 |
chr18_77159557_77160137 | 4.97 |
NFATC1 |
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
475 |
0.86 |
chr17_48943002_48943431 | 4.97 |
TOB1 |
transducer of ERBB2, 1 |
490 |
0.6 |
chr16_3014681_3015078 | 4.96 |
KREMEN2 |
kringle containing transmembrane protein 2 |
357 |
0.69 |
chr7_5436621_5436873 | 4.91 |
TNRC18 |
trinucleotide repeat containing 18 |
9087 |
0.16 |
chr15_75494605_75495154 | 4.86 |
C15orf39 |
chromosome 15 open reading frame 39 |
333 |
0.82 |
chr10_82214211_82214515 | 4.83 |
TSPAN14 |
tetraspanin 14 |
252 |
0.93 |
chr12_117536177_117536841 | 4.81 |
TESC |
tescalcin |
742 |
0.76 |
chr8_101321788_101322100 | 4.78 |
RNF19A |
ring finger protein 19A, RBR E3 ubiquitin protein ligase |
190 |
0.96 |
chr12_113494960_113495179 | 4.74 |
DTX1 |
deltex homolog 1 (Drosophila) |
426 |
0.82 |
chr7_101460259_101460698 | 4.73 |
CUX1 |
cut-like homeobox 1 |
404 |
0.87 |
chr2_45975_46264 | 4.71 |
FAM110C |
family with sequence similarity 110, member C |
266 |
0.95 |
chr20_4803550_4804195 | 4.69 |
RASSF2 |
Ras association (RalGDS/AF-6) domain family member 2 |
419 |
0.85 |
chr5_7869360_7869764 | 4.66 |
MTRR |
5-methyltetrahydrofolate-homocysteine methyltransferase reductase |
210 |
0.71 |
chr22_50630477_50630948 | 4.66 |
RP3-402G11.25 |
|
119 |
0.86 |
chr16_9185604_9185758 | 4.61 |
C16orf72 |
chromosome 16 open reading frame 72 |
176 |
0.94 |
chr11_2323518_2323777 | 4.61 |
TSPAN32 |
tetraspanin 32 |
267 |
0.57 |
chr7_72935956_72936258 | 4.60 |
BAZ1B |
bromodomain adjacent to zinc finger domain, 1B |
495 |
0.75 |
chr15_77289158_77289399 | 4.56 |
PSTPIP1 |
proline-serine-threonine phosphatase interacting protein 1 |
1363 |
0.44 |
chr20_62272433_62273064 | 4.54 |
STMN3 |
stathmin-like 3 |
11371 |
0.09 |
chr2_98611816_98612023 | 4.49 |
TMEM131 |
transmembrane protein 131 |
435 |
0.89 |
chr7_30324618_30324897 | 4.48 |
ZNRF2 |
zinc and ring finger 2 |
834 |
0.64 |
chr21_46238108_46238576 | 4.48 |
SUMO3 |
small ubiquitin-like modifier 3 |
298 |
0.85 |
chr19_17439012_17439348 | 4.47 |
ANO8 |
anoctamin 8 |
6458 |
0.08 |
chr20_4802726_4803481 | 4.46 |
RASSF2 |
Ras association (RalGDS/AF-6) domain family member 2 |
1188 |
0.5 |
chr14_65346567_65346953 | 4.44 |
SPTB |
spectrin, beta, erythrocytic |
159 |
0.94 |
chr18_3012840_3013077 | 4.43 |
LPIN2 |
lipin 2 |
355 |
0.86 |
chr3_50375104_50375696 | 4.43 |
RASSF1 |
Ras association (RalGDS/AF-6) domain family member 1 |
264 |
0.76 |
chr17_28706240_28706541 | 4.41 |
CPD |
carboxypeptidase D |
467 |
0.76 |
chr13_113864040_113864325 | 4.41 |
CUL4A |
cullin 4A |
324 |
0.79 |
chr1_234614585_234614936 | 4.38 |
TARBP1 |
TAR (HIV-1) RNA binding protein 1 |
89 |
0.98 |
chr16_9056918_9057158 | 4.36 |
USP7 |
ubiquitin specific peptidase 7 (herpes virus-associated) |
303 |
0.91 |
chr10_135089818_135090113 | 4.36 |
ADAM8 |
ADAM metallopeptidase domain 8 |
389 |
0.74 |
chr17_43299403_43299689 | 4.31 |
CTD-2020K17.1 |
|
43 |
0.75 |
chrX_3761532_3762024 | 4.31 |
RP11-706O15.1 |
HCG1981372, isoform CRA_c; Uncharacterized protein |
120 |
0.98 |
chr16_81349076_81349337 | 4.30 |
GAN |
gigaxonin |
649 |
0.67 |
chr14_24605460_24605695 | 4.30 |
PSME1 |
proteasome (prosome, macropain) activator subunit 1 (PA28 alpha) |
141 |
0.86 |
chr14_104181272_104181674 | 4.29 |
XRCC3 |
X-ray repair complementing defective repair in Chinese hamster cells 3 |
307 |
0.62 |
chr8_65710999_65711587 | 4.27 |
CYP7B1 |
cytochrome P450, family 7, subfamily B, polypeptide 1 |
25 |
0.99 |
chr9_114393597_114394006 | 4.27 |
DNAJC25 |
DnaJ (Hsp40) homolog, subfamily C , member 25 |
135 |
0.49 |
chr22_41697652_41698202 | 4.26 |
ZC3H7B |
zinc finger CCCH-type containing 7B |
401 |
0.79 |
chr15_52121866_52123371 | 4.25 |
TMOD3 |
tropomodulin 3 (ubiquitous) |
791 |
0.61 |
chr8_146052287_146052584 | 4.24 |
ZNF7 |
zinc finger protein 7 |
414 |
0.75 |
chr9_139009603_139010211 | 4.24 |
C9orf69 |
chromosome 9 open reading frame 69 |
213 |
0.94 |
chr7_3083277_3083584 | 4.24 |
CARD11 |
caspase recruitment domain family, member 11 |
49 |
0.98 |
chr1_182360957_182361120 | 4.24 |
GLUL |
glutamate-ammonia ligase |
111 |
0.97 |
chr6_119399577_119399871 | 4.23 |
FAM184A |
family with sequence similarity 184, member A |
184 |
0.95 |
chr17_73874128_73874630 | 4.22 |
TRIM47 |
tripartite motif containing 47 |
102 |
0.91 |
chr10_35625988_35626510 | 4.22 |
CCNY |
cyclin Y |
447 |
0.7 |
chr2_24713646_24713947 | 4.21 |
NCOA1 |
nuclear receptor coactivator 1 |
1005 |
0.64 |
chr20_278292_278479 | 4.21 |
ZCCHC3 |
zinc finger, CCHC domain containing 3 |
648 |
0.6 |
chr22_50638721_50639285 | 4.20 |
RP3-402G11.26 |
|
27 |
0.84 |
chr2_8825543_8825998 | 4.20 |
ID2 |
inhibitor of DNA binding 2, dominant negative helix-loop-helix protein |
3584 |
0.27 |
chr14_69282780_69283493 | 4.19 |
ZFP36L1 |
ZFP36 ring finger protein-like 1 |
19946 |
0.19 |
chr20_62369505_62369786 | 4.17 |
RP4-583P15.14 |
|
22 |
0.92 |
chr11_2324171_2324374 | 4.13 |
TSPAN32 |
tetraspanin 32 |
174 |
0.88 |
chr17_20945868_20946375 | 4.11 |
USP22 |
ubiquitin specific peptidase 22 |
231 |
0.93 |
chr7_149194315_149194584 | 4.11 |
ZNF746 |
zinc finger protein 746 |
375 |
0.89 |
chr17_2240971_2241301 | 4.10 |
SGSM2 |
small G protein signaling modulator 2 |
220 |
0.6 |
chr5_107717232_107717910 | 4.10 |
FBXL17 |
F-box and leucine-rich repeat protein 17 |
228 |
0.97 |
chr19_3136242_3137376 | 4.10 |
GNA15 |
guanine nucleotide binding protein (G protein), alpha 15 (Gq class) |
618 |
0.58 |
chr22_21056169_21056915 | 4.10 |
POM121L4P |
POM121 transmembrane nucleoporin-like 4 pseudogene |
12325 |
0.13 |
chr19_8510156_8510458 | 4.09 |
HNRNPM |
heterogeneous nuclear ribonucleoprotein M |
429 |
0.73 |
chr17_16256516_16256704 | 4.08 |
CENPV |
centromere protein V |
160 |
0.94 |
chr13_52377985_52378296 | 4.08 |
DHRS12 |
dehydrogenase/reductase (SDR family) member 12 |
94 |
0.76 |
chr17_73840046_73840332 | 4.07 |
UNC13D |
unc-13 homolog D (C. elegans) |
226 |
0.84 |
chr8_144952195_144952400 | 4.07 |
EPPK1 |
epiplakin 1 |
335 |
0.79 |
chr11_316138_316595 | 4.06 |
RP11-326C3.11 |
|
2274 |
0.11 |
chr14_102228260_102228519 | 4.06 |
PPP2R5C |
protein phosphatase 2, regulatory subunit B', gamma |
152 |
0.95 |
chr22_25961017_25961859 | 4.04 |
ADRBK2 |
adrenergic, beta, receptor kinase 2 |
622 |
0.55 |
chr21_16437486_16437824 | 4.04 |
NRIP1 |
nuclear receptor interacting protein 1 |
334 |
0.93 |
chr2_10091040_10091475 | 4.04 |
GRHL1 |
grainyhead-like 1 (Drosophila) |
535 |
0.79 |
chr11_68608574_68609035 | 4.03 |
CPT1A |
carnitine palmitoyltransferase 1A (liver) |
580 |
0.77 |
chr22_40057938_40058206 | 4.01 |
CACNA1I |
calcium channel, voltage-dependent, T type, alpha 1I subunit |
91314 |
0.07 |
chr2_223725769_223726044 | 4.00 |
ACSL3 |
acyl-CoA synthetase long-chain family member 3 |
162 |
0.97 |
chr12_120972117_120972563 | 3.99 |
COQ5 |
coenzyme Q5 homolog, methyltransferase (S. cerevisiae) |
103 |
0.6 |
chr9_95570477_95570696 | 3.99 |
ANKRD19P |
ankyrin repeat domain 19, pseudogene |
1307 |
0.42 |
chr9_35829202_35829460 | 3.99 |
TMEM8B |
transmembrane protein 8B |
102 |
0.86 |
chr10_105726864_105727229 | 3.96 |
SLK |
STE20-like kinase |
87 |
0.97 |
chr19_2290091_2290388 | 3.96 |
LINGO3 |
leucine rich repeat and Ig domain containing 3 |
1784 |
0.18 |
chr1_41327679_41328070 | 3.94 |
CITED4 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4 |
144 |
0.94 |
chr1_1564774_1565122 | 3.93 |
MIB2 |
mindbomb E3 ubiquitin protein ligase 2 |
1079 |
0.29 |
chr3_13056686_13056902 | 3.93 |
IQSEC1 |
IQ motif and Sec7 domain 1 |
28258 |
0.23 |
chr6_20402144_20402837 | 3.92 |
E2F3 |
E2F transcription factor 3 |
92 |
0.96 |
chr3_41240580_41240931 | 3.92 |
CTNNB1 |
catenin (cadherin-associated protein), beta 1, 88kDa |
170 |
0.98 |
chr6_135503685_135504285 | 3.92 |
MYB |
v-myb avian myeloblastosis viral oncogene homolog |
1333 |
0.44 |
chr3_133969553_133969766 | 3.91 |
RYK |
receptor-like tyrosine kinase |
30 |
0.99 |
chr11_2324787_2325062 | 3.91 |
TSPAN32 |
tetraspanin 32 |
826 |
0.45 |
chr9_135038389_135038692 | 3.91 |
NTNG2 |
netrin G2 |
1206 |
0.56 |
chr19_13213099_13213611 | 3.90 |
LYL1 |
lymphoblastic leukemia derived sequence 1 |
326 |
0.79 |
chr20_43279687_43280217 | 3.89 |
ADA |
adenosine deaminase |
380 |
0.81 |
chr7_129251866_129252047 | 3.88 |
NRF1 |
nuclear respiratory factor 1 |
359 |
0.9 |
chr8_37699008_37699734 | 3.88 |
BRF2 |
BRF2, RNA polymerase III transcription initiation factor 50 kDa subunit |
7985 |
0.16 |
chr15_45694566_45695165 | 3.88 |
SPATA5L1 |
spermatogenesis associated 5-like 1 |
297 |
0.59 |
chr19_6481304_6482171 | 3.87 |
DENND1C |
DENN/MADD domain containing 1C |
27 |
0.95 |
chr8_143808632_143809054 | 3.87 |
THEM6 |
thioesterase superfamily member 6 |
222 |
0.45 |
chr17_76121987_76122243 | 3.87 |
TMC6 |
transmembrane channel-like 6 |
986 |
0.4 |
chr12_76477913_76478352 | 3.87 |
NAP1L1 |
nucleosome assembly protein 1-like 1 |
258 |
0.93 |
chr10_124134278_124134675 | 3.86 |
PLEKHA1 |
pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1 |
126 |
0.96 |
chr22_50242881_50243371 | 3.86 |
ZBED4 |
zinc finger, BED-type containing 4 |
4364 |
0.21 |
chr4_1796827_1797107 | 3.86 |
FGFR3 |
fibroblast growth factor receptor 3 |
1344 |
0.42 |
chr20_57224690_57225235 | 3.86 |
STX16 |
syntaxin 16 |
1366 |
0.39 |
chr16_2265076_2265283 | 3.85 |
PGP |
phosphoglycolate phosphatase |
371 |
0.61 |
chr17_76836765_76836916 | 3.85 |
USP36 |
ubiquitin specific peptidase 36 |
23 |
0.97 |
chr11_416834_417350 | 3.85 |
SIGIRR |
single immunoglobulin and toll-interleukin 1 receptor (TIR) domain |
233 |
0.85 |
chr17_48227122_48227652 | 3.84 |
PPP1R9B |
protein phosphatase 1, regulatory subunit 9B |
490 |
0.64 |
chr9_35072054_35072271 | 3.84 |
VCP |
valosin containing protein |
151 |
0.91 |
chr6_3751810_3752094 | 3.84 |
PXDC1 |
PX domain containing 1 |
308 |
0.72 |
chr1_7831350_7831659 | 3.83 |
VAMP3 |
vesicle-associated membrane protein 3 |
175 |
0.93 |
chr19_12833178_12833372 | 3.82 |
TNPO2 |
transportin 2 |
64 |
0.92 |
chr1_153918834_153919140 | 3.82 |
DENND4B |
DENN/MADD domain containing 4B |
185 |
0.88 |
chr10_121485586_121485901 | 3.82 |
INPP5F |
inositol polyphosphate-5-phosphatase F |
134 |
0.97 |
chr17_56410108_56410593 | 3.81 |
MIR142 |
microRNA 142 |
481 |
0.66 |
chr11_57243949_57244502 | 3.81 |
RP11-624G17.3 |
|
782 |
0.45 |
chr11_73087458_73087910 | 3.81 |
RELT |
RELT tumor necrosis factor receptor |
29 |
0.97 |
chr7_138145136_138145700 | 3.81 |
TRIM24 |
tripartite motif containing 24 |
238 |
0.94 |
chr16_67571972_67572459 | 3.80 |
FAM65A |
family with sequence similarity 65, member A |
234 |
0.82 |
chr9_136150814_136151142 | 3.80 |
ENSG00000201843 |
. |
26975 |
0.09 |
chr3_5229473_5230342 | 3.80 |
AC026202.1 |
Uncharacterized protein |
75 |
0.56 |
chr22_17601691_17602165 | 3.79 |
CECR6 |
cat eye syndrome chromosome region, candidate 6 |
215 |
0.77 |
chr12_2904145_2904429 | 3.79 |
FKBP4 |
FK506 binding protein 4, 59kDa |
168 |
0.92 |
chr3_25705652_25705988 | 3.78 |
TOP2B |
topoisomerase (DNA) II beta 180kDa |
32 |
0.93 |
chr4_1004642_1005092 | 3.78 |
FGFRL1 |
fibroblast growth factor receptor-like 1 |
743 |
0.56 |
chr14_91883760_91884222 | 3.78 |
CCDC88C |
coiled-coil domain containing 88C |
130 |
0.97 |
chr20_3026739_3027121 | 3.77 |
MRPS26 |
mitochondrial ribosomal protein S26 |
339 |
0.8 |
chr9_137217336_137217895 | 3.77 |
RXRA |
retinoid X receptor, alpha |
811 |
0.72 |
chr10_73847731_73848399 | 3.77 |
SPOCK2 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 |
21 |
0.98 |
chr6_64282916_64283107 | 3.77 |
PTP4A1 |
protein tyrosine phosphatase type IVA, member 1 |
425 |
0.65 |
chr1_15736508_15737107 | 3.76 |
EFHD2 |
EF-hand domain family, member D2 |
46 |
0.97 |
chr3_122233391_122233733 | 3.76 |
KPNA1 |
karyopherin alpha 1 (importin alpha 5) |
173 |
0.95 |
chr3_33155595_33155944 | 3.75 |
CRTAP |
cartilage associated protein |
223 |
0.91 |
chr5_74348957_74349108 | 3.75 |
GCNT4 |
glucosaminyl (N-acetyl) transferase 4, core 2 |
22308 |
0.25 |
chr11_65339892_65340265 | 3.74 |
FAM89B |
family with sequence similarity 89, member B |
79 |
0.91 |
chr5_102594552_102594973 | 3.74 |
C5orf30 |
chromosome 5 open reading frame 30 |
25 |
0.98 |
chr8_124553468_124553740 | 3.74 |
FBXO32 |
F-box protein 32 |
158 |
0.96 |
chr12_117536981_117537237 | 3.74 |
TESC |
tescalcin |
142 |
0.97 |
chr12_96793768_96794206 | 3.73 |
CDK17 |
cyclin-dependent kinase 17 |
135 |
0.96 |
chr8_146052992_146053214 | 3.73 |
ZNF7 |
zinc finger protein 7 |
100 |
0.94 |
chr19_54875923_54876565 | 3.73 |
LAIR1 |
leukocyte-associated immunoglobulin-like receptor 1 |
170 |
0.91 |
chr1_35657917_35658364 | 3.72 |
SFPQ |
splicing factor proline/glutamine-rich |
609 |
0.7 |
chr14_77786841_77787155 | 3.71 |
POMT2 |
protein-O-mannosyltransferase 2 |
229 |
0.48 |
chr17_61777673_61777989 | 3.71 |
LIMD2 |
LIM domain containing 2 |
214 |
0.92 |
chr21_45661777_45662023 | 3.70 |
ICOSLG |
inducible T-cell co-stimulator ligand |
1051 |
0.37 |
chr17_263385_263906 | 3.70 |
AC108004.3 |
|
169 |
0.93 |
chr1_234744755_234744925 | 3.70 |
IRF2BP2 |
interferon regulatory factor 2 binding protein 2 |
431 |
0.8 |
chr3_152880165_152880606 | 3.69 |
RAP2B |
RAP2B, member of RAS oncogene family |
356 |
0.75 |
chr9_140117422_140117971 | 3.69 |
C9orf169 |
chromosome 9 open reading frame 169 |
1391 |
0.14 |
chr5_175964065_175964400 | 3.69 |
RNF44 |
ring finger protein 44 |
189 |
0.91 |
chr22_37881738_37882044 | 3.69 |
MFNG |
MFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
534 |
0.71 |
chr19_17515989_17516450 | 3.68 |
BST2 |
bone marrow stromal cell antigen 2 |
238 |
0.54 |
chr10_135090163_135090314 | 3.68 |
ADAM8 |
ADAM metallopeptidase domain 8 |
116 |
0.93 |
chr6_35265630_35266434 | 3.68 |
DEF6 |
differentially expressed in FDCP 6 homolog (mouse) |
403 |
0.84 |
chr3_197354198_197354750 | 3.68 |
AC024560.3 |
|
245 |
0.93 |
chr19_16254556_16255035 | 3.67 |
HSH2D |
hematopoietic SH2 domain containing |
249 |
0.88 |
chr2_202507510_202508172 | 3.67 |
TMEM237 |
transmembrane protein 237 |
174 |
0.94 |
chr17_80170886_80171308 | 3.67 |
CCDC57 |
coiled-coil domain containing 57 |
408 |
0.65 |
chr17_55162734_55163425 | 3.66 |
AKAP1 |
A kinase (PRKA) anchor protein 1 |
1 |
0.98 |
chr17_74448855_74449165 | 3.66 |
UBE2O |
ubiquitin-conjugating enzyme E2O |
278 |
0.6 |
chr17_54910886_54911269 | 3.65 |
C17orf67 |
chromosome 17 open reading frame 67 |
179 |
0.72 |
chrX_39957338_39957651 | 3.65 |
BCOR |
BCL6 corepressor |
838 |
0.77 |
chr17_7141304_7141505 | 3.65 |
PHF23 |
PHD finger protein 23 |
86 |
0.9 |
chr1_20960010_20960411 | 3.65 |
PINK1 |
PTEN induced putative kinase 1 |
262 |
0.91 |
chr16_2826706_2827078 | 3.64 |
TCEB2 |
transcription elongation factor B (SIII), polypeptide 2 (18kDa, elongin B) |
236 |
0.82 |
chrX_3799973_3800438 | 3.64 |
RP11-706O15.1 |
HCG1981372, isoform CRA_c; Uncharacterized protein |
38307 |
0.22 |
chr7_1543718_1544009 | 3.64 |
INTS1 |
integrator complex subunit 1 |
140 |
0.94 |
chr15_29131227_29131499 | 3.63 |
APBA2 |
amyloid beta (A4) precursor protein-binding, family A, member 2 |
54 |
0.98 |
chr9_99180680_99180947 | 3.63 |
ZNF367 |
zinc finger protein 367 |
202 |
0.95 |
chr19_2083107_2083981 | 3.62 |
MOB3A |
MOB kinase activator 3A |
1847 |
0.21 |
chrX_9433454_9434167 | 3.62 |
TBL1X |
transducin (beta)-like 1X-linked |
476 |
0.9 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.0 | 20.9 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
6.5 | 19.5 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
5.3 | 15.8 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
4.9 | 14.8 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
4.5 | 22.4 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
4.5 | 17.8 | GO:0048541 | Peyer's patch development(GO:0048541) |
4.4 | 17.8 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
4.4 | 4.4 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
4.3 | 12.9 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
4.1 | 20.7 | GO:0007386 | compartment pattern specification(GO:0007386) |
4.1 | 12.4 | GO:0061526 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) acetylcholine secretion(GO:0061526) |
4.0 | 16.0 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
3.9 | 19.5 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
3.9 | 7.8 | GO:0030223 | neutrophil differentiation(GO:0030223) |
3.9 | 19.4 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
3.8 | 11.5 | GO:0010957 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
3.8 | 15.3 | GO:0034063 | stress granule assembly(GO:0034063) |
3.8 | 3.8 | GO:0060219 | camera-type eye photoreceptor cell differentiation(GO:0060219) |
3.8 | 7.5 | GO:0070669 | response to interleukin-2(GO:0070669) |
3.7 | 14.8 | GO:0043374 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
3.7 | 11.0 | GO:0046940 | nucleoside monophosphate phosphorylation(GO:0046940) |
3.6 | 7.3 | GO:0072216 | positive regulation of metanephros development(GO:0072216) |
3.6 | 3.6 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
3.6 | 7.2 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
3.6 | 10.8 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
3.4 | 10.2 | GO:0007571 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
3.4 | 10.2 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
3.3 | 13.4 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
3.3 | 19.9 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
3.3 | 6.6 | GO:1900121 | regulation of receptor binding(GO:1900120) negative regulation of receptor binding(GO:1900121) |
3.3 | 9.9 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
3.2 | 3.2 | GO:0032649 | interferon-gamma production(GO:0032609) regulation of interferon-gamma production(GO:0032649) |
3.2 | 9.7 | GO:1901534 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
3.2 | 6.4 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
3.2 | 6.4 | GO:0000212 | meiotic spindle organization(GO:0000212) |
3.2 | 6.4 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
3.2 | 3.2 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
3.2 | 3.2 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
3.1 | 6.2 | GO:0022038 | corpus callosum development(GO:0022038) |
3.1 | 27.9 | GO:0002467 | germinal center formation(GO:0002467) |
3.1 | 18.5 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
3.1 | 12.3 | GO:0000089 | mitotic metaphase(GO:0000089) |
3.0 | 3.0 | GO:0051014 | actin filament severing(GO:0051014) |
3.0 | 9.1 | GO:0070670 | response to interleukin-4(GO:0070670) |
3.0 | 3.0 | GO:0051297 | microtubule organizing center organization(GO:0031023) centrosome organization(GO:0051297) |
3.0 | 12.0 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
3.0 | 3.0 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
3.0 | 50.4 | GO:0046834 | lipid phosphorylation(GO:0046834) |
3.0 | 11.9 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
2.9 | 8.8 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
2.9 | 8.8 | GO:0001821 | histamine secretion(GO:0001821) |
2.9 | 5.9 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
2.9 | 11.7 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
2.9 | 45.7 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
2.9 | 11.4 | GO:0034629 | cellular protein complex localization(GO:0034629) |
2.9 | 2.9 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
2.8 | 8.5 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
2.8 | 14.2 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
2.8 | 8.4 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
2.8 | 2.8 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
2.8 | 14.0 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
2.8 | 11.2 | GO:0021801 | cerebral cortex radial glia guided migration(GO:0021801) telencephalon glial cell migration(GO:0022030) |
2.8 | 2.8 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) negative regulation of nitric-oxide synthase activity(GO:0051001) |
2.7 | 16.5 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
2.7 | 5.4 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
2.7 | 2.7 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
2.7 | 8.0 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
2.6 | 5.3 | GO:0010761 | fibroblast migration(GO:0010761) |
2.6 | 2.6 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
2.6 | 7.9 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
2.6 | 10.5 | GO:0019388 | galactose catabolic process(GO:0019388) |
2.6 | 10.5 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
2.6 | 2.6 | GO:0005997 | xylulose metabolic process(GO:0005997) |
2.6 | 2.6 | GO:0000279 | M phase(GO:0000279) |
2.6 | 2.6 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
2.6 | 5.2 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
2.6 | 10.3 | GO:0019987 | obsolete negative regulation of anti-apoptosis(GO:0019987) |
2.6 | 2.6 | GO:0006642 | triglyceride mobilization(GO:0006642) |
2.6 | 2.6 | GO:0036473 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
2.6 | 7.7 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
2.6 | 12.8 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
2.6 | 20.5 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
2.6 | 7.7 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
2.5 | 7.4 | GO:0032928 | regulation of superoxide anion generation(GO:0032928) |
2.5 | 7.4 | GO:0022417 | protein maturation by protein folding(GO:0022417) |
2.5 | 7.4 | GO:0043276 | anoikis(GO:0043276) |
2.5 | 2.5 | GO:0015811 | sulfur amino acid transport(GO:0000101) L-cystine transport(GO:0015811) |
2.4 | 4.9 | GO:0007405 | neuroblast proliferation(GO:0007405) |
2.4 | 4.9 | GO:0007144 | female meiosis I(GO:0007144) |
2.4 | 2.4 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
2.4 | 9.7 | GO:0045040 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
2.4 | 7.3 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
2.4 | 7.2 | GO:0032803 | regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) regulation of receptor catabolic process(GO:2000644) |
2.4 | 12.0 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
2.4 | 7.2 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
2.4 | 7.2 | GO:0009191 | nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
2.4 | 16.8 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
2.4 | 4.8 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
2.4 | 2.4 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
2.4 | 30.9 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
2.4 | 4.7 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
2.4 | 7.1 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
2.4 | 18.8 | GO:0046902 | regulation of mitochondrial membrane permeability(GO:0046902) regulation of membrane permeability(GO:0090559) |
2.4 | 2.4 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
2.4 | 11.8 | GO:0007256 | activation of JNKK activity(GO:0007256) |
2.3 | 4.7 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
2.3 | 7.0 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
2.3 | 2.3 | GO:0051340 | regulation of ligase activity(GO:0051340) |
2.3 | 21.0 | GO:0051322 | anaphase(GO:0051322) |
2.3 | 7.0 | GO:0031507 | heterochromatin assembly(GO:0031507) heterochromatin organization(GO:0070828) |
2.3 | 7.0 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) regulation of lamellipodium organization(GO:1902743) |
2.3 | 11.6 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
2.3 | 7.0 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
2.3 | 9.2 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
2.3 | 6.9 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
2.3 | 6.9 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
2.3 | 2.3 | GO:0001845 | phagolysosome assembly(GO:0001845) phagosome maturation(GO:0090382) |
2.3 | 6.8 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
2.3 | 4.5 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
2.3 | 6.8 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
2.3 | 13.6 | GO:0097061 | dendritic spine morphogenesis(GO:0060997) regulation of dendritic spine morphogenesis(GO:0061001) dendritic spine organization(GO:0097061) |
2.3 | 15.8 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
2.3 | 4.5 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
2.3 | 11.3 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
2.3 | 6.8 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
2.2 | 4.5 | GO:0035246 | peptidyl-arginine methylation(GO:0018216) peptidyl-arginine N-methylation(GO:0035246) |
2.2 | 11.2 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
2.2 | 6.7 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) regulation of store-operated calcium channel activity(GO:1901339) positive regulation of store-operated calcium channel activity(GO:1901341) |
2.2 | 6.7 | GO:0046548 | retinal rod cell development(GO:0046548) |
2.2 | 2.2 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
2.2 | 4.5 | GO:0071816 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
2.2 | 11.1 | GO:0051382 | kinetochore assembly(GO:0051382) |
2.2 | 2.2 | GO:0046398 | UDP-glucuronate metabolic process(GO:0046398) |
2.2 | 8.8 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
2.2 | 11.0 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
2.2 | 6.6 | GO:0051832 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
2.2 | 6.6 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
2.2 | 4.4 | GO:0003057 | regulation of the force of heart contraction by chemical signal(GO:0003057) |
2.2 | 8.8 | GO:0051642 | centrosome localization(GO:0051642) |
2.2 | 8.8 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
2.2 | 11.0 | GO:0045793 | positive regulation of cell size(GO:0045793) |
2.2 | 8.8 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
2.2 | 17.5 | GO:0007172 | signal complex assembly(GO:0007172) |
2.2 | 48.1 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
2.2 | 6.6 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
2.2 | 8.7 | GO:0051570 | negative regulation of histone methylation(GO:0031061) regulation of histone H3-K9 methylation(GO:0051570) |
2.2 | 6.5 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
2.2 | 4.3 | GO:0090200 | positive regulation of mitochondrion organization(GO:0010822) positive regulation of release of cytochrome c from mitochondria(GO:0090200) positive regulation of apoptotic signaling pathway(GO:2001235) |
2.1 | 12.9 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
2.1 | 21.2 | GO:0007020 | microtubule nucleation(GO:0007020) |
2.1 | 8.5 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
2.1 | 6.3 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
2.1 | 8.4 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
2.1 | 4.2 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
2.1 | 8.4 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
2.1 | 2.1 | GO:0001743 | optic placode formation(GO:0001743) |
2.1 | 18.7 | GO:0035308 | negative regulation of dephosphorylation(GO:0035305) negative regulation of protein dephosphorylation(GO:0035308) |
2.1 | 12.5 | GO:0045910 | negative regulation of DNA recombination(GO:0045910) |
2.1 | 10.3 | GO:0002820 | negative regulation of adaptive immune response(GO:0002820) negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains(GO:0002823) |
2.1 | 4.1 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
2.1 | 24.7 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
2.1 | 6.2 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
2.1 | 16.4 | GO:0006013 | mannose metabolic process(GO:0006013) |
2.0 | 2.0 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
2.0 | 6.1 | GO:0016559 | peroxisome fission(GO:0016559) |
2.0 | 14.2 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
2.0 | 14.1 | GO:0006265 | DNA topological change(GO:0006265) |
2.0 | 2.0 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
2.0 | 2.0 | GO:0006906 | vesicle fusion(GO:0006906) |
2.0 | 2.0 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
2.0 | 8.0 | GO:0060539 | diaphragm development(GO:0060539) |
2.0 | 6.0 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
2.0 | 2.0 | GO:0070527 | platelet aggregation(GO:0070527) |
2.0 | 4.0 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
2.0 | 13.9 | GO:0002063 | chondrocyte development(GO:0002063) |
2.0 | 5.9 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
2.0 | 7.9 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
2.0 | 2.0 | GO:0090311 | regulation of protein deacetylation(GO:0090311) |
2.0 | 5.9 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
2.0 | 7.9 | GO:1903313 | positive regulation of mRNA 3'-end processing(GO:0031442) positive regulation of mRNA processing(GO:0050685) positive regulation of mRNA metabolic process(GO:1903313) |
2.0 | 21.7 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
2.0 | 5.9 | GO:0043173 | nucleotide salvage(GO:0043173) |
2.0 | 5.9 | GO:0032025 | response to cobalt ion(GO:0032025) |
2.0 | 5.9 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
2.0 | 3.9 | GO:0051447 | negative regulation of meiotic cell cycle(GO:0051447) |
2.0 | 5.9 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
2.0 | 2.0 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
1.9 | 7.8 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
1.9 | 9.7 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
1.9 | 11.6 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
1.9 | 1.9 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
1.9 | 3.8 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
1.9 | 9.6 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
1.9 | 1.9 | GO:0010833 | telomere maintenance via telomere lengthening(GO:0010833) |
1.9 | 11.4 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
1.9 | 7.6 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
1.9 | 3.8 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
1.9 | 5.7 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
1.9 | 1.9 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
1.9 | 13.2 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
1.9 | 5.6 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) negative regulation of protein acetylation(GO:1901984) negative regulation of peptidyl-lysine acetylation(GO:2000757) |
1.9 | 1.9 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) regulation of cellular response to insulin stimulus(GO:1900076) |
1.9 | 22.5 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
1.9 | 3.7 | GO:0010916 | regulation of very-low-density lipoprotein particle clearance(GO:0010915) negative regulation of very-low-density lipoprotein particle clearance(GO:0010916) negative regulation of lipoprotein particle clearance(GO:0010985) |
1.9 | 9.3 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
1.9 | 1.9 | GO:0034135 | regulation of toll-like receptor 2 signaling pathway(GO:0034135) |
1.9 | 5.6 | GO:1903504 | positive regulation of spindle checkpoint(GO:0090232) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) regulation of mitotic spindle checkpoint(GO:1903504) |
1.9 | 9.3 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
1.8 | 3.7 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
1.8 | 3.7 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
1.8 | 1.8 | GO:0003197 | endocardial cushion development(GO:0003197) |
1.8 | 3.7 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
1.8 | 1.8 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
1.8 | 3.7 | GO:0032060 | bleb assembly(GO:0032060) |
1.8 | 1.8 | GO:0033158 | regulation of protein import into nucleus, translocation(GO:0033158) |
1.8 | 5.5 | GO:0032801 | receptor catabolic process(GO:0032801) |
1.8 | 21.8 | GO:0016925 | protein sumoylation(GO:0016925) |
1.8 | 3.6 | GO:0061008 | liver development(GO:0001889) hepaticobiliary system development(GO:0061008) |
1.8 | 14.5 | GO:0034311 | diol metabolic process(GO:0034311) |
1.8 | 7.2 | GO:0015853 | adenine transport(GO:0015853) |
1.8 | 1.8 | GO:2000008 | regulation of protein localization to cell surface(GO:2000008) |
1.8 | 5.4 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
1.8 | 1.8 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
1.8 | 1.8 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
1.8 | 17.8 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
1.8 | 1.8 | GO:0016572 | histone phosphorylation(GO:0016572) |
1.8 | 1.8 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
1.8 | 5.3 | GO:0006266 | DNA ligation(GO:0006266) |
1.8 | 5.3 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
1.8 | 3.5 | GO:0033622 | integrin activation(GO:0033622) |
1.8 | 95.5 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
1.8 | 8.8 | GO:0039703 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
1.8 | 1.8 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
1.8 | 5.3 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid(GO:0034625) |
1.8 | 22.9 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
1.8 | 15.8 | GO:0043097 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
1.8 | 5.3 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
1.8 | 14.0 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
1.7 | 3.5 | GO:0032776 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
1.7 | 5.2 | GO:0042921 | glucocorticoid receptor signaling pathway(GO:0042921) |
1.7 | 8.7 | GO:0006983 | ER overload response(GO:0006983) |
1.7 | 10.5 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
1.7 | 1.7 | GO:0051145 | smooth muscle cell differentiation(GO:0051145) |
1.7 | 8.6 | GO:0021681 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
1.7 | 3.5 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
1.7 | 6.9 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
1.7 | 29.4 | GO:0008633 | obsolete activation of pro-apoptotic gene products(GO:0008633) |
1.7 | 6.9 | GO:0006999 | nuclear pore organization(GO:0006999) |
1.7 | 5.2 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
1.7 | 3.4 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
1.7 | 5.1 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
1.7 | 5.1 | GO:0003283 | atrial septum development(GO:0003283) atrial septum morphogenesis(GO:0060413) |
1.7 | 6.8 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
1.7 | 23.7 | GO:0016578 | histone deubiquitination(GO:0016578) |
1.7 | 5.1 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
1.7 | 15.2 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
1.7 | 3.4 | GO:0030581 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) regulation by virus of viral protein levels in host cell(GO:0046719) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
1.7 | 1.7 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
1.7 | 5.0 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
1.7 | 15.1 | GO:0009147 | pyrimidine nucleoside triphosphate metabolic process(GO:0009147) |
1.7 | 3.4 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
1.7 | 3.3 | GO:0072676 | lymphocyte chemotaxis(GO:0048247) lymphocyte migration(GO:0072676) |
1.7 | 1.7 | GO:0060119 | inner ear receptor cell development(GO:0060119) |
1.7 | 18.3 | GO:0016180 | snRNA processing(GO:0016180) |
1.7 | 5.0 | GO:1901215 | negative regulation of neuron apoptotic process(GO:0043524) negative regulation of neuron death(GO:1901215) |
1.7 | 11.6 | GO:0014037 | Schwann cell differentiation(GO:0014037) |
1.7 | 5.0 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
1.7 | 1.7 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
1.7 | 1.7 | GO:0002679 | respiratory burst involved in defense response(GO:0002679) |
1.7 | 1.7 | GO:0042100 | B cell proliferation(GO:0042100) |
1.7 | 77.8 | GO:0031295 | lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
1.6 | 8.2 | GO:0008089 | anterograde axonal transport(GO:0008089) |
1.6 | 1.6 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
1.6 | 11.5 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
1.6 | 3.3 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
1.6 | 8.2 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
1.6 | 8.2 | GO:0001881 | receptor recycling(GO:0001881) |
1.6 | 4.9 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
1.6 | 11.5 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
1.6 | 6.5 | GO:0019985 | translesion synthesis(GO:0019985) |
1.6 | 8.1 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
1.6 | 6.5 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
1.6 | 1.6 | GO:0009299 | mRNA transcription(GO:0009299) |
1.6 | 1.6 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
1.6 | 6.4 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
1.6 | 1.6 | GO:1902745 | positive regulation of lamellipodium assembly(GO:0010592) positive regulation of lamellipodium organization(GO:1902745) |
1.6 | 12.8 | GO:0034976 | response to endoplasmic reticulum stress(GO:0034976) |
1.6 | 3.2 | GO:0045341 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) |
1.6 | 4.8 | GO:0008634 | obsolete negative regulation of survival gene product expression(GO:0008634) |
1.6 | 3.2 | GO:0032202 | telomere assembly(GO:0032202) |
1.6 | 4.8 | GO:0018094 | protein polyglycylation(GO:0018094) |
1.6 | 33.3 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
1.6 | 4.7 | GO:0071428 | rRNA-containing ribonucleoprotein complex export from nucleus(GO:0071428) |
1.6 | 4.7 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
1.6 | 3.2 | GO:0060057 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
1.6 | 6.3 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
1.6 | 15.7 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
1.6 | 9.4 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
1.6 | 4.7 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
1.6 | 6.3 | GO:0032329 | serine transport(GO:0032329) |
1.6 | 4.7 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
1.6 | 7.8 | GO:0045116 | protein neddylation(GO:0045116) |
1.6 | 6.2 | GO:0034453 | microtubule anchoring(GO:0034453) |
1.6 | 34.2 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
1.6 | 1.6 | GO:0050773 | regulation of dendrite development(GO:0050773) |
1.6 | 6.2 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
1.5 | 3.1 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
1.5 | 1.5 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
1.5 | 1.5 | GO:0046134 | pyrimidine nucleoside biosynthetic process(GO:0046134) |
1.5 | 1.5 | GO:0048261 | negative regulation of receptor-mediated endocytosis(GO:0048261) |
1.5 | 3.1 | GO:0097502 | protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) mannosylation(GO:0097502) |
1.5 | 1.5 | GO:0060972 | left/right pattern formation(GO:0060972) |
1.5 | 3.1 | GO:0051665 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) membrane raft localization(GO:0051665) |
1.5 | 3.1 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
1.5 | 6.2 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
1.5 | 1.5 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) regulation of bile acid metabolic process(GO:1904251) |
1.5 | 6.1 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
1.5 | 3.1 | GO:0002230 | positive regulation of defense response to virus by host(GO:0002230) |
1.5 | 4.6 | GO:0071436 | sodium ion export(GO:0071436) |
1.5 | 3.1 | GO:0048291 | isotype switching to IgG isotypes(GO:0048291) |
1.5 | 6.1 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
1.5 | 9.1 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
1.5 | 59.3 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
1.5 | 4.6 | GO:0060897 | neural plate anterior/posterior regionalization(GO:0021999) neural plate regionalization(GO:0060897) |
1.5 | 10.6 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
1.5 | 1.5 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
1.5 | 69.7 | GO:0000288 | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:0000288) |
1.5 | 16.6 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
1.5 | 6.0 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
1.5 | 13.6 | GO:0045022 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
1.5 | 1.5 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
1.5 | 9.0 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
1.5 | 3.0 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
1.5 | 10.5 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
1.5 | 3.0 | GO:1903332 | regulation of protein folding(GO:1903332) |
1.5 | 4.5 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
1.5 | 28.3 | GO:0006611 | protein export from nucleus(GO:0006611) |
1.5 | 4.5 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
1.5 | 7.4 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
1.5 | 5.9 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
1.5 | 3.0 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
1.5 | 7.4 | GO:0001866 | NK T cell proliferation(GO:0001866) |
1.5 | 1.5 | GO:0014874 | response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
1.5 | 4.4 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
1.5 | 5.9 | GO:0043248 | proteasome assembly(GO:0043248) |
1.5 | 1.5 | GO:0090501 | RNA phosphodiester bond hydrolysis(GO:0090501) |
1.5 | 2.9 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
1.5 | 1.5 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
1.5 | 1.5 | GO:0002085 | inhibition of neuroepithelial cell differentiation(GO:0002085) |
1.5 | 7.3 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
1.5 | 30.7 | GO:0006270 | DNA replication initiation(GO:0006270) |
1.5 | 2.9 | GO:0046021 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
1.5 | 10.2 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
1.5 | 2.9 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
1.5 | 13.1 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
1.5 | 5.8 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
1.5 | 5.8 | GO:0097191 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
1.5 | 4.4 | GO:0000239 | pachytene(GO:0000239) |
1.4 | 1.4 | GO:2000041 | regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
1.4 | 4.3 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
1.4 | 4.3 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
1.4 | 10.1 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
1.4 | 1.4 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
1.4 | 8.7 | GO:0016584 | nucleosome positioning(GO:0016584) |
1.4 | 30.3 | GO:0043966 | histone H3 acetylation(GO:0043966) |
1.4 | 2.9 | GO:1901862 | negative regulation of striated muscle tissue development(GO:0045843) negative regulation of muscle organ development(GO:0048635) negative regulation of muscle tissue development(GO:1901862) |
1.4 | 2.9 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
1.4 | 2.9 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
1.4 | 2.9 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
1.4 | 7.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
1.4 | 4.3 | GO:0006448 | regulation of translational elongation(GO:0006448) |
1.4 | 11.4 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
1.4 | 1.4 | GO:0032682 | negative regulation of chemokine production(GO:0032682) |
1.4 | 7.1 | GO:0030851 | granulocyte differentiation(GO:0030851) |
1.4 | 2.8 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
1.4 | 4.3 | GO:0051409 | response to nitrosative stress(GO:0051409) |
1.4 | 5.7 | GO:1900274 | positive regulation of phospholipase C activity(GO:0010863) regulation of phospholipase C activity(GO:1900274) |
1.4 | 1.4 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
1.4 | 8.5 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
1.4 | 1.4 | GO:0001955 | blood vessel maturation(GO:0001955) |
1.4 | 7.0 | GO:0042832 | defense response to protozoan(GO:0042832) |
1.4 | 11.3 | GO:0044349 | nucleotide-excision repair, DNA damage removal(GO:0000718) DNA excision(GO:0044349) |
1.4 | 2.8 | GO:0097576 | vacuole fusion(GO:0097576) |
1.4 | 1.4 | GO:0015851 | nucleobase transport(GO:0015851) |
1.4 | 2.8 | GO:0002274 | myeloid leukocyte activation(GO:0002274) |
1.4 | 26.6 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
1.4 | 11.2 | GO:1904031 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
1.4 | 2.8 | GO:0019042 | viral latency(GO:0019042) |
1.4 | 2.8 | GO:0030011 | maintenance of cell polarity(GO:0030011) |
1.4 | 1.4 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
1.4 | 9.7 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
1.4 | 6.9 | GO:0045749 | obsolete negative regulation of S phase of mitotic cell cycle(GO:0045749) |
1.4 | 13.8 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
1.4 | 4.1 | GO:0010447 | response to acidic pH(GO:0010447) |
1.4 | 45.5 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
1.4 | 4.1 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
1.4 | 1.4 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
1.4 | 1.4 | GO:1902692 | regulation of neuroblast proliferation(GO:1902692) |
1.4 | 20.6 | GO:0016574 | histone ubiquitination(GO:0016574) |
1.4 | 9.6 | GO:1903078 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
1.4 | 25.9 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) ERAD pathway(GO:0036503) |
1.4 | 13.6 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
1.4 | 2.7 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
1.4 | 19.0 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
1.4 | 4.1 | GO:0031297 | replication fork processing(GO:0031297) |
1.4 | 8.1 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
1.4 | 2.7 | GO:2000816 | negative regulation of mitotic sister chromatid segregation(GO:0033048) negative regulation of mitotic metaphase/anaphase transition(GO:0045841) mitotic spindle checkpoint(GO:0071174) negative regulation of metaphase/anaphase transition of cell cycle(GO:1902100) negative regulation of mitotic sister chromatid separation(GO:2000816) |
1.3 | 9.4 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
1.3 | 6.7 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
1.3 | 4.0 | GO:0030091 | protein repair(GO:0030091) |
1.3 | 4.0 | GO:0009301 | snRNA transcription(GO:0009301) |
1.3 | 24.1 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
1.3 | 2.7 | GO:0034339 | obsolete regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor(GO:0034339) |
1.3 | 14.7 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.3 | 6.7 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) |
1.3 | 4.0 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
1.3 | 4.0 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
1.3 | 1.3 | GO:0051775 | response to redox state(GO:0051775) |
1.3 | 5.3 | GO:0008593 | regulation of Notch signaling pathway(GO:0008593) |
1.3 | 6.6 | GO:0006561 | proline biosynthetic process(GO:0006561) |
1.3 | 18.4 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
1.3 | 2.6 | GO:0033598 | mammary gland epithelial cell proliferation(GO:0033598) |
1.3 | 1.3 | GO:0016458 | gene silencing(GO:0016458) |
1.3 | 2.6 | GO:0045638 | negative regulation of myeloid cell differentiation(GO:0045638) |
1.3 | 3.9 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
1.3 | 3.9 | GO:2000144 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) positive regulation of DNA-templated transcription, initiation(GO:2000144) |
1.3 | 1.3 | GO:0048041 | cell-substrate adherens junction assembly(GO:0007045) focal adhesion assembly(GO:0048041) |
1.3 | 1.3 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
1.3 | 63.6 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) G1 DNA damage checkpoint(GO:0044783) mitotic G1/S transition checkpoint(GO:0044819) |
1.3 | 3.9 | GO:0046479 | glycosylceramide catabolic process(GO:0046477) glycosphingolipid catabolic process(GO:0046479) |
1.3 | 1.3 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
1.3 | 3.9 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
1.3 | 3.9 | GO:0051898 | negative regulation of protein kinase B signaling(GO:0051898) |
1.3 | 5.2 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
1.3 | 25.8 | GO:0030183 | B cell differentiation(GO:0030183) |
1.3 | 1.3 | GO:0043174 | nucleoside salvage(GO:0043174) |
1.3 | 9.0 | GO:0006376 | mRNA splice site selection(GO:0006376) |
1.3 | 2.6 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
1.3 | 2.6 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
1.3 | 1.3 | GO:0000085 | mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
1.3 | 5.1 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
1.3 | 6.4 | GO:0032366 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
1.3 | 2.6 | GO:0007021 | tubulin complex assembly(GO:0007021) |
1.3 | 2.5 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
1.3 | 21.6 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
1.3 | 7.6 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
1.3 | 2.5 | GO:0034723 | DNA replication-dependent nucleosome organization(GO:0034723) |
1.3 | 224.9 | GO:0016568 | chromatin modification(GO:0016568) |
1.3 | 6.3 | GO:0006388 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
1.3 | 3.8 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
1.3 | 3.8 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
1.3 | 5.0 | GO:0002098 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
1.3 | 1.3 | GO:0048318 | axial mesoderm development(GO:0048318) |
1.3 | 2.5 | GO:0051000 | positive regulation of nitric-oxide synthase activity(GO:0051000) |
1.3 | 3.8 | GO:0040001 | establishment of mitotic spindle localization(GO:0040001) |
1.2 | 1.2 | GO:0006927 | obsolete transformed cell apoptotic process(GO:0006927) |
1.2 | 3.7 | GO:0045683 | negative regulation of epidermis development(GO:0045683) |
1.2 | 1.2 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
1.2 | 3.7 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
1.2 | 7.4 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
1.2 | 3.7 | GO:0030952 | establishment or maintenance of cytoskeleton polarity(GO:0030952) |
1.2 | 64.2 | GO:0006413 | translational initiation(GO:0006413) |
1.2 | 18.5 | GO:0035384 | thioester biosynthetic process(GO:0035384) acyl-CoA biosynthetic process(GO:0071616) |
1.2 | 1.2 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
1.2 | 8.6 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
1.2 | 3.7 | GO:0009188 | ADP biosynthetic process(GO:0006172) purine nucleoside diphosphate biosynthetic process(GO:0009136) purine ribonucleoside diphosphate biosynthetic process(GO:0009180) ribonucleoside diphosphate biosynthetic process(GO:0009188) |
1.2 | 1.2 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
1.2 | 12.2 | GO:0009084 | glutamine family amino acid biosynthetic process(GO:0009084) |
1.2 | 4.9 | GO:0006379 | mRNA cleavage(GO:0006379) |
1.2 | 6.1 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
1.2 | 1.2 | GO:0010988 | regulation of low-density lipoprotein particle clearance(GO:0010988) regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
1.2 | 1.2 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
1.2 | 2.4 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
1.2 | 3.6 | GO:0032354 | response to follicle-stimulating hormone(GO:0032354) |
1.2 | 2.4 | GO:0072659 | protein localization to plasma membrane(GO:0072659) protein localization to cell periphery(GO:1990778) |
1.2 | 2.4 | GO:0045010 | actin nucleation(GO:0045010) |
1.2 | 2.4 | GO:0051168 | nuclear export(GO:0051168) |
1.2 | 2.4 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) |
1.2 | 2.4 | GO:0072599 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
1.2 | 14.3 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
1.2 | 17.9 | GO:0030593 | neutrophil chemotaxis(GO:0030593) neutrophil migration(GO:1990266) |
1.2 | 11.9 | GO:0042770 | signal transduction in response to DNA damage(GO:0042770) |
1.2 | 82.0 | GO:0050658 | nucleic acid transport(GO:0050657) RNA transport(GO:0050658) establishment of RNA localization(GO:0051236) |
1.2 | 4.7 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
1.2 | 2.4 | GO:0034505 | tooth mineralization(GO:0034505) |
1.2 | 8.3 | GO:0006098 | pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
1.2 | 3.5 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
1.2 | 1.2 | GO:0016075 | rRNA catabolic process(GO:0016075) |
1.2 | 17.6 | GO:0019079 | viral genome replication(GO:0019079) |
1.2 | 2.3 | GO:0001709 | cell fate determination(GO:0001709) |
1.2 | 1.2 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
1.2 | 2.3 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
1.2 | 5.8 | GO:0031648 | protein destabilization(GO:0031648) |
1.2 | 38.5 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
1.2 | 9.3 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
1.2 | 4.7 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
1.2 | 12.8 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
1.2 | 9.3 | GO:0006282 | regulation of DNA repair(GO:0006282) |
1.2 | 3.5 | GO:0007000 | nucleolus organization(GO:0007000) |
1.2 | 1.2 | GO:0035581 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
1.2 | 20.9 | GO:0031397 | negative regulation of protein ubiquitination(GO:0031397) |
1.2 | 13.9 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
1.2 | 2.3 | GO:0042420 | dopamine catabolic process(GO:0042420) |
1.2 | 2.3 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
1.2 | 10.4 | GO:0051865 | protein autoubiquitination(GO:0051865) |
1.2 | 4.6 | GO:0016553 | base conversion or substitution editing(GO:0016553) |
1.2 | 3.5 | GO:0016093 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
1.2 | 1.2 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) maturation of LSU-rRNA(GO:0000470) |
1.2 | 2.3 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
1.1 | 17.2 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
1.1 | 114.9 | GO:0000398 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
1.1 | 20.7 | GO:0031396 | regulation of protein ubiquitination(GO:0031396) |
1.1 | 3.4 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
1.1 | 4.6 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
1.1 | 3.4 | GO:0032091 | negative regulation of protein binding(GO:0032091) |
1.1 | 3.4 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
1.1 | 16.0 | GO:0016236 | macroautophagy(GO:0016236) |
1.1 | 2.3 | GO:0006390 | mitochondrial RNA metabolic process(GO:0000959) transcription from mitochondrial promoter(GO:0006390) |
1.1 | 1.1 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
1.1 | 6.8 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
1.1 | 12.5 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
1.1 | 28.4 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
1.1 | 32.9 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
1.1 | 3.4 | GO:0048625 | myoblast fate commitment(GO:0048625) |
1.1 | 3.4 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
1.1 | 1.1 | GO:0018343 | protein farnesylation(GO:0018343) |
1.1 | 1.1 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) |
1.1 | 12.4 | GO:0007006 | mitochondrial membrane organization(GO:0007006) |
1.1 | 1.1 | GO:0006491 | N-glycan processing(GO:0006491) |
1.1 | 13.5 | GO:0043526 | obsolete neuroprotection(GO:0043526) |
1.1 | 10.1 | GO:0007520 | syncytium formation by plasma membrane fusion(GO:0000768) myoblast fusion(GO:0007520) |
1.1 | 1.1 | GO:0072498 | embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
1.1 | 2.3 | GO:0006998 | nuclear envelope organization(GO:0006998) |
1.1 | 1.1 | GO:0006612 | protein targeting to membrane(GO:0006612) |
1.1 | 4.5 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
1.1 | 3.4 | GO:0033345 | asparagine catabolic process(GO:0006530) asparagine catabolic process via L-aspartate(GO:0033345) |
1.1 | 3.4 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
1.1 | 20.1 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
1.1 | 5.6 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
1.1 | 1.1 | GO:0070672 | response to interleukin-15(GO:0070672) |
1.1 | 6.7 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
1.1 | 2.2 | GO:1902099 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
1.1 | 5.6 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
1.1 | 1.1 | GO:0016199 | axon choice point recognition(GO:0016198) axon midline choice point recognition(GO:0016199) |
1.1 | 14.4 | GO:0000084 | mitotic S phase(GO:0000084) |
1.1 | 5.6 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
1.1 | 17.8 | GO:0006672 | ceramide metabolic process(GO:0006672) |
1.1 | 3.3 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
1.1 | 10.0 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
1.1 | 7.7 | GO:0006105 | succinate metabolic process(GO:0006105) |
1.1 | 1.1 | GO:0035725 | sodium ion transmembrane transport(GO:0035725) |
1.1 | 2.2 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
1.1 | 39.6 | GO:0030833 | regulation of actin filament polymerization(GO:0030833) |
1.1 | 1.1 | GO:0014897 | cardiac muscle hypertrophy(GO:0003300) striated muscle hypertrophy(GO:0014897) |
1.1 | 11.0 | GO:0008380 | RNA splicing(GO:0008380) |
1.1 | 5.5 | GO:0009129 | pyrimidine nucleoside monophosphate metabolic process(GO:0009129) |
1.1 | 81.9 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
1.1 | 3.3 | GO:0045814 | negative regulation of gene expression, epigenetic(GO:0045814) |
1.1 | 3.3 | GO:0050931 | melanocyte differentiation(GO:0030318) pigment cell differentiation(GO:0050931) |
1.1 | 1.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
1.1 | 5.4 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
1.1 | 1.1 | GO:0006536 | glutamate metabolic process(GO:0006536) |
1.1 | 6.5 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
1.1 | 13.0 | GO:0007052 | mitotic spindle organization(GO:0007052) |
1.1 | 3.2 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
1.1 | 5.4 | GO:0009304 | tRNA transcription(GO:0009304) |
1.1 | 9.7 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
1.1 | 1.1 | GO:0043372 | positive regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043372) positive regulation of CD4-positive, alpha-beta T cell activation(GO:2000516) |
1.1 | 4.3 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
1.1 | 2.1 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
1.1 | 18.0 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
1.1 | 3.2 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
1.1 | 3.2 | GO:1903307 | positive regulation of myeloid leukocyte mediated immunity(GO:0002888) positive regulation of mast cell activation(GO:0033005) positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of leukocyte degranulation(GO:0043302) positive regulation of mast cell degranulation(GO:0043306) positive regulation of regulated secretory pathway(GO:1903307) |
1.1 | 1.1 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
1.1 | 5.3 | GO:0006857 | oligopeptide transport(GO:0006857) |
1.1 | 6.3 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
1.1 | 5.3 | GO:0050684 | regulation of mRNA processing(GO:0050684) regulation of mRNA metabolic process(GO:1903311) |
1.1 | 1.1 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
1.1 | 2.1 | GO:0032755 | positive regulation of interleukin-6 production(GO:0032755) |
1.1 | 1.1 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
1.1 | 5.3 | GO:0046039 | GTP metabolic process(GO:0046039) |
1.1 | 2.1 | GO:0032925 | regulation of activin receptor signaling pathway(GO:0032925) |
1.0 | 2.1 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
1.0 | 3.1 | GO:0008088 | axo-dendritic transport(GO:0008088) |
1.0 | 1.0 | GO:0042035 | regulation of cytokine biosynthetic process(GO:0042035) |
1.0 | 2.1 | GO:0033240 | positive regulation of cellular amine metabolic process(GO:0033240) |
1.0 | 8.3 | GO:0032456 | endocytic recycling(GO:0032456) |
1.0 | 3.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
1.0 | 2.1 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
1.0 | 2.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
1.0 | 1.0 | GO:0008216 | spermidine metabolic process(GO:0008216) |
1.0 | 10.2 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
1.0 | 3.1 | GO:0072666 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
1.0 | 4.1 | GO:0046149 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
1.0 | 4.1 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
1.0 | 4.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
1.0 | 8.1 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
1.0 | 7.1 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
1.0 | 4.0 | GO:0033047 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) regulation of mitotic sister chromatid separation(GO:0010965) regulation of mitotic sister chromatid segregation(GO:0033047) metaphase/anaphase transition of cell cycle(GO:0044784) mitotic sister chromatid separation(GO:0051306) |
1.0 | 1.0 | GO:0045086 | positive regulation of interleukin-2 biosynthetic process(GO:0045086) |
1.0 | 2.0 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
1.0 | 14.1 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
1.0 | 8.0 | GO:0018107 | peptidyl-threonine phosphorylation(GO:0018107) |
1.0 | 5.0 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
1.0 | 6.0 | GO:0045730 | respiratory burst(GO:0045730) |
1.0 | 5.0 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
1.0 | 1.0 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
1.0 | 1.0 | GO:0071459 | protein localization to kinetochore(GO:0034501) protein localization to chromosome, centromeric region(GO:0071459) |
1.0 | 5.0 | GO:0060017 | parathyroid gland development(GO:0060017) |
1.0 | 7.0 | GO:0045840 | positive regulation of mitotic nuclear division(GO:0045840) |
1.0 | 1.0 | GO:0050688 | regulation of defense response to virus(GO:0050688) |
1.0 | 4.0 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
1.0 | 1.0 | GO:0080111 | DNA demethylation(GO:0080111) |
1.0 | 2.0 | GO:0006154 | adenosine catabolic process(GO:0006154) |
1.0 | 3.0 | GO:0051593 | response to folic acid(GO:0051593) |
1.0 | 6.9 | GO:0045408 | regulation of interleukin-6 biosynthetic process(GO:0045408) |
1.0 | 8.9 | GO:0007032 | endosome organization(GO:0007032) |
1.0 | 2.0 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
1.0 | 5.9 | GO:0051597 | response to methylmercury(GO:0051597) |
1.0 | 8.8 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
1.0 | 19.5 | GO:0016579 | protein deubiquitination(GO:0016579) |
1.0 | 1.0 | GO:0010824 | regulation of centrosome duplication(GO:0010824) regulation of centrosome cycle(GO:0046605) |
1.0 | 1.9 | GO:0001714 | endodermal cell fate commitment(GO:0001711) endodermal cell fate specification(GO:0001714) endodermal cell differentiation(GO:0035987) regulation of endodermal cell fate specification(GO:0042663) regulation of endodermal cell differentiation(GO:1903224) |
1.0 | 18.5 | GO:0007051 | spindle organization(GO:0007051) |
1.0 | 6.8 | GO:0015813 | L-glutamate transport(GO:0015813) |
1.0 | 2.9 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
1.0 | 1.9 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
1.0 | 1.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
1.0 | 3.8 | GO:0051452 | intracellular pH reduction(GO:0051452) |
1.0 | 90.1 | GO:0016071 | mRNA metabolic process(GO:0016071) |
1.0 | 1.9 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
1.0 | 1.0 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
1.0 | 1.9 | GO:0007412 | axon target recognition(GO:0007412) |
1.0 | 1.0 | GO:0002507 | tolerance induction(GO:0002507) |
1.0 | 1.9 | GO:0009405 | pathogenesis(GO:0009405) |
1.0 | 2.9 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
1.0 | 1.9 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.9 | 1.9 | GO:0009156 | ribonucleoside monophosphate biosynthetic process(GO:0009156) |
0.9 | 1.9 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.9 | 0.9 | GO:0060080 | inhibitory postsynaptic potential(GO:0060080) |
0.9 | 2.8 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.9 | 4.7 | GO:0051928 | positive regulation of calcium ion transport(GO:0051928) |
0.9 | 4.7 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.9 | 0.9 | GO:2000095 | regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000095) |
0.9 | 4.7 | GO:0032873 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.9 | 5.6 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.9 | 67.7 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.9 | 2.8 | GO:0045056 | transcytosis(GO:0045056) |
0.9 | 2.8 | GO:0051828 | entry into host cell(GO:0030260) entry into host(GO:0044409) entry into cell of other organism involved in symbiotic interaction(GO:0051806) entry into other organism involved in symbiotic interaction(GO:0051828) |
0.9 | 3.7 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.9 | 0.9 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.9 | 0.9 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.9 | 14.8 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.9 | 90.6 | GO:0019941 | modification-dependent protein catabolic process(GO:0019941) modification-dependent macromolecule catabolic process(GO:0043632) |
0.9 | 0.9 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.9 | 1.8 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.9 | 12.9 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.9 | 62.6 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.9 | 3.7 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.9 | 90.0 | GO:0006184 | obsolete GTP catabolic process(GO:0006184) |
0.9 | 4.6 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.9 | 13.8 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
0.9 | 29.3 | GO:0009185 | ribonucleoside diphosphate metabolic process(GO:0009185) ADP metabolic process(GO:0046031) |
0.9 | 0.9 | GO:0003181 | heart valve development(GO:0003170) atrioventricular valve development(GO:0003171) heart valve morphogenesis(GO:0003179) atrioventricular valve morphogenesis(GO:0003181) |
0.9 | 18.2 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.9 | 2.7 | GO:0045123 | cellular extravasation(GO:0045123) |
0.9 | 2.7 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.9 | 0.9 | GO:0006997 | nucleus organization(GO:0006997) |
0.9 | 11.8 | GO:0000080 | mitotic G1 phase(GO:0000080) |
0.9 | 5.4 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.9 | 2.7 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.9 | 0.9 | GO:1901264 | carbohydrate derivative transport(GO:1901264) |
0.9 | 4.5 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.9 | 5.4 | GO:0009303 | rRNA transcription(GO:0009303) |
0.9 | 1.8 | GO:0031929 | TOR signaling(GO:0031929) |
0.9 | 0.9 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.9 | 3.6 | GO:0006479 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
0.9 | 2.7 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.9 | 1.8 | GO:0045655 | regulation of monocyte differentiation(GO:0045655) |
0.9 | 0.9 | GO:0060412 | ventricular septum morphogenesis(GO:0060412) |
0.9 | 7.1 | GO:0015992 | proton transport(GO:0015992) |
0.9 | 0.9 | GO:2001259 | positive regulation of calcium ion transmembrane transporter activity(GO:1901021) positive regulation of cation channel activity(GO:2001259) |
0.9 | 1.8 | GO:0055064 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.9 | 1.8 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.9 | 1.8 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.9 | 9.6 | GO:0006662 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.9 | 1.7 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.9 | 0.9 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.9 | 41.6 | GO:0006826 | iron ion transport(GO:0006826) |
0.9 | 4.3 | GO:0015074 | DNA integration(GO:0015074) |
0.9 | 2.6 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.9 | 1.7 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.9 | 1.7 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.9 | 1.7 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.9 | 0.9 | GO:0006490 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.8 | 0.8 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.8 | 2.5 | GO:1902806 | regulation of cell cycle G1/S phase transition(GO:1902806) regulation of G1/S transition of mitotic cell cycle(GO:2000045) |
0.8 | 4.2 | GO:0046689 | response to mercury ion(GO:0046689) |
0.8 | 2.5 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.8 | 5.0 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.8 | 5.8 | GO:0050957 | equilibrioception(GO:0050957) |
0.8 | 1.7 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.8 | 0.8 | GO:0014805 | smooth muscle adaptation(GO:0014805) |
0.8 | 6.6 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.8 | 2.5 | GO:0051298 | centrosome duplication(GO:0051298) |
0.8 | 0.8 | GO:0048002 | antigen processing and presentation of peptide antigen(GO:0048002) |
0.8 | 19.8 | GO:0000236 | mitotic prometaphase(GO:0000236) |
0.8 | 5.0 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
0.8 | 21.4 | GO:0006458 | 'de novo' protein folding(GO:0006458) |
0.8 | 4.1 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.8 | 4.1 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.8 | 2.5 | GO:0001570 | vasculogenesis(GO:0001570) |
0.8 | 1.6 | GO:0032733 | positive regulation of interleukin-10 production(GO:0032733) |
0.8 | 15.5 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.8 | 3.3 | GO:1902603 | carnitine shuttle(GO:0006853) intracellular lipid transport(GO:0032365) carnitine transmembrane transport(GO:1902603) |
0.8 | 43.8 | GO:0008033 | tRNA processing(GO:0008033) |
0.8 | 3.2 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.8 | 7.3 | GO:0006306 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.8 | 32.3 | GO:0006364 | rRNA processing(GO:0006364) |
0.8 | 2.4 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.8 | 3.2 | GO:0000154 | rRNA modification(GO:0000154) |
0.8 | 0.8 | GO:0002720 | positive regulation of cytokine production involved in immune response(GO:0002720) |
0.8 | 64.4 | GO:0006325 | chromatin organization(GO:0006325) |
0.8 | 54.4 | GO:0006415 | translational termination(GO:0006415) |
0.8 | 66.2 | GO:0006457 | protein folding(GO:0006457) |
0.8 | 19.1 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) |
0.8 | 8.8 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.8 | 3.2 | GO:0000050 | urea cycle(GO:0000050) |
0.8 | 3.2 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.8 | 1.6 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.8 | 5.6 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.8 | 13.5 | GO:0005980 | glycogen catabolic process(GO:0005980) |
0.8 | 2.4 | GO:0032309 | icosanoid secretion(GO:0032309) |
0.8 | 0.8 | GO:0050832 | defense response to fungus(GO:0050832) |
0.8 | 0.8 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
0.8 | 17.2 | GO:0006914 | autophagy(GO:0006914) |
0.8 | 3.9 | GO:0034612 | response to tumor necrosis factor(GO:0034612) |
0.8 | 3.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.8 | 4.7 | GO:0006839 | mitochondrial transport(GO:0006839) |
0.8 | 1.6 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.8 | 120.2 | GO:0044419 | interspecies interaction between organisms(GO:0044419) |
0.8 | 1.6 | GO:0032459 | regulation of protein oligomerization(GO:0032459) |
0.8 | 5.5 | GO:0009067 | aspartate family amino acid biosynthetic process(GO:0009067) |
0.8 | 0.8 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.8 | 3.8 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.8 | 15.3 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.8 | 3.8 | GO:0000087 | mitotic M phase(GO:0000087) |
0.8 | 27.2 | GO:0006396 | RNA processing(GO:0006396) |
0.8 | 7.6 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
0.8 | 0.8 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.8 | 0.8 | GO:0001840 | neural plate morphogenesis(GO:0001839) neural plate development(GO:0001840) |
0.8 | 0.8 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.8 | 6.8 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
0.8 | 7.5 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.7 | 0.7 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.7 | 123.5 | GO:0006412 | translation(GO:0006412) |
0.7 | 7.5 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.7 | 0.7 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.7 | 3.0 | GO:0018342 | protein prenylation(GO:0018342) prenylation(GO:0097354) |
0.7 | 5.9 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
0.7 | 1.5 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.7 | 3.0 | GO:0009103 | lipopolysaccharide biosynthetic process(GO:0009103) |
0.7 | 11.1 | GO:0051169 | nuclear transport(GO:0051169) |
0.7 | 1.5 | GO:0002294 | CD4-positive, alpha-beta T cell differentiation involved in immune response(GO:0002294) T-helper cell differentiation(GO:0042093) |
0.7 | 0.7 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.7 | 0.7 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.7 | 1.5 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
0.7 | 1.5 | GO:0033363 | secretory granule organization(GO:0033363) |
0.7 | 3.6 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.7 | 32.7 | GO:0016567 | protein ubiquitination(GO:0016567) |
0.7 | 2.9 | GO:0000012 | single strand break repair(GO:0000012) |
0.7 | 1.5 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.7 | 0.7 | GO:0046634 | regulation of alpha-beta T cell activation(GO:0046634) |
0.7 | 2.2 | GO:0021754 | facial nucleus development(GO:0021754) |
0.7 | 10.1 | GO:1901607 | alpha-amino acid biosynthetic process(GO:1901607) |
0.7 | 2.9 | GO:0002418 | immune response to tumor cell(GO:0002418) |
0.7 | 0.7 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.7 | 7.2 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.7 | 3.6 | GO:0006903 | vesicle targeting(GO:0006903) |
0.7 | 67.3 | GO:0006281 | DNA repair(GO:0006281) |
0.7 | 1.4 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.7 | 7.9 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.7 | 1.4 | GO:0021702 | cerebellar Purkinje cell layer morphogenesis(GO:0021692) cerebellar Purkinje cell layer formation(GO:0021694) cerebellar Purkinje cell differentiation(GO:0021702) |
0.7 | 1.4 | GO:0055078 | sodium ion homeostasis(GO:0055078) |
0.7 | 1.4 | GO:0033483 | oxygen homeostasis(GO:0032364) gas homeostasis(GO:0033483) |
0.7 | 38.3 | GO:0097190 | apoptotic signaling pathway(GO:0097190) |
0.7 | 0.7 | GO:0061036 | positive regulation of cartilage development(GO:0061036) |
0.7 | 7.1 | GO:0007219 | Notch signaling pathway(GO:0007219) |
0.7 | 7.8 | GO:0030097 | hemopoiesis(GO:0030097) |
0.7 | 4.2 | GO:0006465 | signal peptide processing(GO:0006465) |
0.7 | 2.1 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.7 | 0.7 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.7 | 4.9 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.7 | 1.4 | GO:0061371 | heart looping(GO:0001947) embryonic heart tube morphogenesis(GO:0003143) determination of heart left/right asymmetry(GO:0061371) |
0.7 | 1.4 | GO:0018200 | peptidyl-glutamic acid modification(GO:0018200) |
0.7 | 1.4 | GO:0006721 | terpenoid metabolic process(GO:0006721) |
0.7 | 0.7 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.7 | 2.8 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.7 | 4.1 | GO:0044065 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) regulation of respiratory system process(GO:0044065) |
0.7 | 2.7 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.7 | 1.4 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.7 | 4.1 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.7 | 1.4 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.7 | 6.8 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.7 | 1.4 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.7 | 1.4 | GO:0015793 | glycerol transport(GO:0015793) |
0.7 | 1.3 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.7 | 4.0 | GO:0007041 | lysosomal transport(GO:0007041) |
0.7 | 2.0 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
0.7 | 2.7 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.7 | 1.3 | GO:0048016 | inositol phosphate-mediated signaling(GO:0048016) |
0.7 | 2.0 | GO:0048505 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.7 | 2.0 | GO:0032446 | protein modification by small protein conjugation(GO:0032446) |
0.7 | 1.3 | GO:0014823 | response to activity(GO:0014823) |
0.7 | 2.0 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.7 | 1.3 | GO:0034030 | nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
0.7 | 1.3 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
0.7 | 1.3 | GO:0006862 | nucleotide transport(GO:0006862) |
0.7 | 4.6 | GO:0010467 | gene expression(GO:0010467) |
0.7 | 2.6 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
0.6 | 1.9 | GO:1903556 | negative regulation of tumor necrosis factor production(GO:0032720) negative regulation of tumor necrosis factor superfamily cytokine production(GO:1903556) |
0.6 | 2.6 | GO:0006101 | citrate metabolic process(GO:0006101) tricarboxylic acid metabolic process(GO:0072350) |
0.6 | 1.3 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) ketone body catabolic process(GO:0046952) |
0.6 | 5.1 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.6 | 0.6 | GO:0032200 | telomere organization(GO:0032200) |
0.6 | 3.2 | GO:0015914 | phospholipid transport(GO:0015914) |
0.6 | 24.3 | GO:0009199 | ribonucleoside triphosphate metabolic process(GO:0009199) purine ribonucleoside triphosphate metabolic process(GO:0009205) |
0.6 | 32.5 | GO:0038179 | neurotrophin signaling pathway(GO:0038179) neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.6 | 23.5 | GO:0006486 | protein glycosylation(GO:0006486) macromolecule glycosylation(GO:0043413) |
0.6 | 2.5 | GO:0046823 | negative regulation of nucleocytoplasmic transport(GO:0046823) |
0.6 | 0.6 | GO:0046471 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
0.6 | 1.3 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.6 | 6.3 | GO:0000187 | activation of MAPK activity(GO:0000187) |
0.6 | 26.2 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.6 | 0.6 | GO:0016048 | detection of temperature stimulus(GO:0016048) detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.6 | 12.4 | GO:0007286 | spermatid development(GO:0007286) |
0.6 | 0.6 | GO:0008653 | lipopolysaccharide metabolic process(GO:0008653) |
0.6 | 1.2 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
0.6 | 1.9 | GO:0046487 | glyoxylate metabolic process(GO:0046487) |
0.6 | 3.1 | GO:0043094 | cellular metabolic compound salvage(GO:0043094) |
0.6 | 1.2 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) metaphase plate congression(GO:0051310) |
0.6 | 3.7 | GO:0002920 | regulation of humoral immune response(GO:0002920) |
0.6 | 0.6 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.6 | 5.5 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.6 | 15.3 | GO:0007602 | phototransduction(GO:0007602) |
0.6 | 1.2 | GO:0019320 | hexose catabolic process(GO:0019320) |
0.6 | 2.4 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
0.6 | 1.8 | GO:0007059 | chromosome segregation(GO:0007059) |
0.6 | 1.8 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) positive regulation of natural killer cell mediated cytotoxicity(GO:0045954) |
0.6 | 3.6 | GO:0009953 | dorsal/ventral pattern formation(GO:0009953) |
0.6 | 8.4 | GO:0009615 | response to virus(GO:0009615) |
0.6 | 1.8 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.6 | 0.6 | GO:0001302 | replicative cell aging(GO:0001302) |
0.6 | 6.0 | GO:0044843 | G1/S transition of mitotic cell cycle(GO:0000082) cell cycle G1/S phase transition(GO:0044843) |
0.6 | 1.8 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
0.6 | 1.2 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.6 | 3.0 | GO:0045214 | sarcomere organization(GO:0045214) |
0.6 | 0.6 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.6 | 8.3 | GO:0005977 | glycogen metabolic process(GO:0005977) |
0.6 | 1.8 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.6 | 0.6 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.6 | 0.6 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.6 | 0.6 | GO:0048799 | ossification involved in bone maturation(GO:0043931) organ maturation(GO:0048799) bone maturation(GO:0070977) |
0.6 | 1.2 | GO:0033688 | regulation of osteoblast proliferation(GO:0033688) |
0.6 | 2.9 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.6 | 2.9 | GO:0045762 | positive regulation of adenylate cyclase activity(GO:0045762) |
0.6 | 2.3 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.6 | 1.2 | GO:0003416 | endochondral bone growth(GO:0003416) growth plate cartilage development(GO:0003417) bone growth(GO:0098868) |
0.6 | 5.8 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.6 | 0.6 | GO:0048566 | embryonic digestive tract development(GO:0048566) |
0.6 | 2.3 | GO:0070206 | protein trimerization(GO:0070206) |
0.6 | 0.6 | GO:0034130 | toll-like receptor 1 signaling pathway(GO:0034130) toll-like receptor 2 signaling pathway(GO:0034134) |
0.6 | 4.6 | GO:0006200 | obsolete ATP catabolic process(GO:0006200) |
0.6 | 1.7 | GO:0007031 | peroxisome organization(GO:0007031) |
0.6 | 1.1 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.6 | 0.6 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.6 | 2.8 | GO:0006546 | glycine catabolic process(GO:0006546) |
0.6 | 7.3 | GO:0006026 | aminoglycan catabolic process(GO:0006026) |
0.6 | 2.2 | GO:0006896 | Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
0.6 | 1.7 | GO:0015886 | heme transport(GO:0015886) iron coordination entity transport(GO:1901678) |
0.6 | 1.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.6 | 11.1 | GO:0007005 | mitochondrion organization(GO:0007005) |
0.6 | 1.1 | GO:0009713 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.6 | 10.5 | GO:0050851 | antigen receptor-mediated signaling pathway(GO:0050851) |
0.5 | 1.1 | GO:0071326 | cellular response to monosaccharide stimulus(GO:0071326) cellular response to hexose stimulus(GO:0071331) cellular response to glucose stimulus(GO:0071333) |
0.5 | 1.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.5 | 16.7 | GO:0006968 | cellular defense response(GO:0006968) |
0.5 | 2.7 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.5 | 1.1 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.5 | 1.6 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
0.5 | 0.5 | GO:0016064 | immunoglobulin mediated immune response(GO:0016064) B cell mediated immunity(GO:0019724) |
0.5 | 0.5 | GO:0097205 | regulation of glomerular filtration(GO:0003093) glomerular filtration(GO:0003094) renal filtration(GO:0097205) regulation of renal system process(GO:0098801) |
0.5 | 1.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.5 | 2.1 | GO:0035329 | hippo signaling(GO:0035329) |
0.5 | 6.8 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.5 | 1.6 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.5 | 11.4 | GO:0034340 | response to type I interferon(GO:0034340) |
0.5 | 0.5 | GO:0031641 | regulation of myelination(GO:0031641) |
0.5 | 2.1 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.5 | 2.1 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.5 | 1.0 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.5 | 0.5 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.5 | 1.0 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.5 | 6.0 | GO:0043401 | steroid hormone mediated signaling pathway(GO:0043401) |
0.5 | 2.5 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.5 | 0.5 | GO:0032846 | positive regulation of homeostatic process(GO:0032846) |
0.5 | 2.0 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.5 | 0.5 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.5 | 0.5 | GO:0045112 | integrin biosynthetic process(GO:0045112) |
0.5 | 1.0 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) carnitine metabolic process(GO:0009437) |
0.5 | 3.4 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.5 | 0.5 | GO:0034660 | ncRNA metabolic process(GO:0034660) |
0.5 | 3.4 | GO:0007030 | Golgi organization(GO:0007030) |
0.5 | 1.5 | GO:0030261 | chromosome condensation(GO:0030261) |
0.5 | 4.4 | GO:0048880 | sensory system development(GO:0048880) lateral line nerve development(GO:0048892) lateral line nerve glial cell differentiation(GO:0048895) lateral line system development(GO:0048925) lateral line nerve glial cell development(GO:0048937) iridophore differentiation(GO:0050935) |
0.5 | 2.9 | GO:0045930 | negative regulation of mitotic cell cycle(GO:0045930) |
0.5 | 3.4 | GO:0015931 | nucleobase-containing compound transport(GO:0015931) |
0.5 | 1.4 | GO:0010039 | response to iron ion(GO:0010039) |
0.5 | 1.0 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.5 | 1.0 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
0.5 | 0.5 | GO:0009880 | embryonic pattern specification(GO:0009880) |
0.5 | 1.9 | GO:0010107 | potassium ion import(GO:0010107) |
0.5 | 1.4 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
0.5 | 5.6 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.5 | 0.5 | GO:0001936 | regulation of endothelial cell proliferation(GO:0001936) |
0.5 | 12.1 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.5 | 0.9 | GO:0015705 | iodide transport(GO:0015705) |
0.5 | 0.5 | GO:0034447 | very-low-density lipoprotein particle clearance(GO:0034447) |
0.5 | 28.2 | GO:0007067 | mitotic nuclear division(GO:0007067) |
0.5 | 0.9 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.5 | 5.5 | GO:0030099 | myeloid cell differentiation(GO:0030099) |
0.5 | 0.9 | GO:0010212 | response to ionizing radiation(GO:0010212) |
0.5 | 1.4 | GO:0090208 | positive regulation of triglyceride metabolic process(GO:0090208) |
0.5 | 0.5 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.5 | 0.9 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.5 | 1.4 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.4 | 1.8 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.4 | 2.7 | GO:0031647 | regulation of protein stability(GO:0031647) |
0.4 | 5.7 | GO:0048278 | vesicle docking(GO:0048278) |
0.4 | 1.8 | GO:0045329 | amino-acid betaine biosynthetic process(GO:0006578) carnitine biosynthetic process(GO:0045329) |
0.4 | 1.3 | GO:0060285 | cilium-dependent cell motility(GO:0060285) |
0.4 | 1.7 | GO:0002682 | regulation of immune system process(GO:0002682) |
0.4 | 4.4 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.4 | 3.0 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.4 | 3.0 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
0.4 | 0.4 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
0.4 | 2.1 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.4 | 5.1 | GO:0019835 | cytolysis(GO:0019835) |
0.4 | 1.7 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.4 | 0.4 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.4 | 0.8 | GO:0006907 | pinocytosis(GO:0006907) |
0.4 | 5.4 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.4 | 0.8 | GO:0046655 | folic acid metabolic process(GO:0046655) |
0.4 | 0.8 | GO:0001510 | RNA methylation(GO:0001510) |
0.4 | 0.8 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.4 | 0.8 | GO:0009415 | response to water(GO:0009415) |
0.4 | 0.4 | GO:0033692 | cellular polysaccharide biosynthetic process(GO:0033692) |
0.4 | 0.4 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.4 | 3.6 | GO:0071593 | T cell activation(GO:0042110) leukocyte aggregation(GO:0070486) T cell aggregation(GO:0070489) lymphocyte aggregation(GO:0071593) |
0.4 | 3.2 | GO:0002021 | response to dietary excess(GO:0002021) |
0.4 | 29.4 | GO:0006470 | protein dephosphorylation(GO:0006470) |
0.4 | 0.4 | GO:0035587 | purinergic receptor signaling pathway(GO:0035587) |
0.4 | 0.4 | GO:0098543 | detection of other organism(GO:0098543) |
0.4 | 5.1 | GO:0032011 | ARF protein signal transduction(GO:0032011) |
0.4 | 1.9 | GO:0006354 | DNA-templated transcription, elongation(GO:0006354) |
0.4 | 1.1 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.4 | 0.4 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
0.4 | 0.4 | GO:0048617 | foregut morphogenesis(GO:0007440) embryonic foregut morphogenesis(GO:0048617) |
0.4 | 1.1 | GO:0042180 | cellular ketone metabolic process(GO:0042180) |
0.4 | 1.9 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.4 | 3.7 | GO:0008344 | adult locomotory behavior(GO:0008344) |
0.4 | 2.2 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.4 | 0.4 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.4 | 2.6 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.4 | 36.6 | GO:0006897 | endocytosis(GO:0006897) |
0.4 | 4.0 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.4 | 1.5 | GO:0006974 | cellular response to DNA damage stimulus(GO:0006974) |
0.4 | 1.8 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.4 | 0.4 | GO:0003016 | respiratory system process(GO:0003016) |
0.4 | 1.1 | GO:0007128 | meiotic prophase I(GO:0007128) |
0.4 | 1.8 | GO:0032259 | methylation(GO:0032259) |
0.4 | 4.7 | GO:0008272 | sulfate transport(GO:0008272) |
0.4 | 0.4 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.4 | 1.4 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.4 | 65.4 | GO:0007264 | small GTPase mediated signal transduction(GO:0007264) |
0.4 | 1.1 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.3 | 0.7 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.3 | 0.3 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.3 | 0.7 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.3 | 0.7 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.3 | 1.0 | GO:0019674 | NAD metabolic process(GO:0019674) |
0.3 | 0.7 | GO:0048535 | lymph node development(GO:0048535) |
0.3 | 1.7 | GO:0045088 | regulation of innate immune response(GO:0045088) |
0.3 | 0.3 | GO:0046330 | positive regulation of JNK cascade(GO:0046330) |
0.3 | 4.7 | GO:0001906 | cell killing(GO:0001906) |
0.3 | 2.4 | GO:0009755 | hormone-mediated signaling pathway(GO:0009755) |
0.3 | 1.0 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.3 | 0.3 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.3 | 3.3 | GO:0007632 | visual behavior(GO:0007632) |
0.3 | 0.7 | GO:0031274 | pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
0.3 | 0.3 | GO:0051006 | positive regulation of lipoprotein lipase activity(GO:0051006) positive regulation of triglyceride lipase activity(GO:0061365) |
0.3 | 0.3 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.3 | 2.6 | GO:0042246 | tissue regeneration(GO:0042246) |
0.3 | 1.0 | GO:0031018 | endocrine pancreas development(GO:0031018) |
0.3 | 1.0 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
0.3 | 9.8 | GO:0045087 | innate immune response(GO:0045087) |
0.3 | 0.3 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.3 | 1.3 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
0.3 | 0.6 | GO:0016125 | sterol metabolic process(GO:0016125) |
0.3 | 0.3 | GO:0002200 | somatic diversification of immune receptors(GO:0002200) |
0.3 | 27.7 | GO:0043087 | regulation of GTPase activity(GO:0043087) |
0.3 | 0.6 | GO:0010629 | negative regulation of gene expression(GO:0010629) |
0.3 | 1.9 | GO:0032526 | response to retinoic acid(GO:0032526) |
0.3 | 1.0 | GO:0048863 | stem cell differentiation(GO:0048863) |
0.3 | 0.6 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
0.3 | 0.9 | GO:0045823 | positive regulation of heart contraction(GO:0045823) |
0.3 | 0.3 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.3 | 1.9 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
0.3 | 0.6 | GO:0009804 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
0.3 | 10.6 | GO:0006959 | humoral immune response(GO:0006959) |
0.3 | 0.6 | GO:0031331 | positive regulation of cellular catabolic process(GO:0031331) |
0.3 | 3.9 | GO:0007179 | transforming growth factor beta receptor signaling pathway(GO:0007179) |
0.3 | 0.9 | GO:0071496 | cellular response to external stimulus(GO:0071496) |
0.3 | 11.9 | GO:0198738 | Wnt signaling pathway(GO:0016055) cell-cell signaling by wnt(GO:0198738) |
0.3 | 4.1 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.3 | 0.6 | GO:0009895 | negative regulation of catabolic process(GO:0009895) |
0.3 | 1.2 | GO:0031100 | organ regeneration(GO:0031100) |
0.3 | 2.6 | GO:0051289 | protein homotetramerization(GO:0051289) |
0.3 | 0.3 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.3 | 0.3 | GO:0006825 | copper ion transport(GO:0006825) |
0.3 | 1.1 | GO:0051341 | regulation of oxidoreductase activity(GO:0051341) |
0.3 | 5.1 | GO:0006665 | sphingolipid metabolic process(GO:0006665) |
0.3 | 0.8 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.3 | 4.5 | GO:0030308 | negative regulation of cell growth(GO:0030308) |
0.3 | 39.2 | GO:0015031 | protein transport(GO:0015031) |
0.3 | 0.3 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.3 | 0.3 | GO:0046325 | negative regulation of glucose transport(GO:0010829) negative regulation of glucose import(GO:0046325) |
0.3 | 1.1 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.3 | 1.1 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.3 | 0.3 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.3 | 1.1 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.3 | 0.3 | GO:0043255 | regulation of carbohydrate biosynthetic process(GO:0043255) |
0.3 | 1.3 | GO:0006310 | DNA recombination(GO:0006310) |
0.3 | 0.5 | GO:0006473 | protein acetylation(GO:0006473) |
0.3 | 0.3 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.3 | 1.8 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.3 | 0.8 | GO:0034762 | regulation of transmembrane transport(GO:0034762) |
0.3 | 1.5 | GO:0006401 | RNA catabolic process(GO:0006401) |
0.3 | 0.3 | GO:0051262 | protein tetramerization(GO:0051262) |
0.3 | 0.3 | GO:0043406 | positive regulation of MAP kinase activity(GO:0043406) |
0.3 | 0.3 | GO:0033014 | tetrapyrrole biosynthetic process(GO:0033014) |
0.3 | 5.3 | GO:0016197 | endosomal transport(GO:0016197) |
0.2 | 1.0 | GO:0006706 | steroid catabolic process(GO:0006706) |
0.2 | 1.7 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.2 | 34.8 | GO:0016192 | vesicle-mediated transport(GO:0016192) |
0.2 | 0.2 | GO:0046877 | regulation of saliva secretion(GO:0046877) |
0.2 | 0.2 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.2 | 0.2 | GO:1905145 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) cellular response to ammonium ion(GO:0071242) acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.2 | 0.5 | GO:0032506 | mitotic cytokinesis(GO:0000281) cytokinetic process(GO:0032506) |
0.2 | 0.5 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.2 | 0.2 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.2 | 0.5 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.2 | 28.9 | GO:0006955 | immune response(GO:0006955) |
0.2 | 0.5 | GO:0032368 | regulation of lipid transport(GO:0032368) |
0.2 | 2.5 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.2 | 0.7 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.2 | 2.5 | GO:0071554 | cell wall macromolecule catabolic process(GO:0016998) cell wall macromolecule metabolic process(GO:0044036) cell wall organization or biogenesis(GO:0071554) |
0.2 | 0.4 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
0.2 | 38.1 | GO:0007049 | cell cycle(GO:0007049) |
0.2 | 0.9 | GO:0006553 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
0.2 | 0.4 | GO:0010883 | regulation of lipid storage(GO:0010883) |
0.2 | 0.2 | GO:0010455 | positive regulation of cell fate commitment(GO:0010455) |
0.2 | 3.0 | GO:0022900 | electron transport chain(GO:0022900) |
0.2 | 0.2 | GO:0061028 | establishment of endothelial barrier(GO:0061028) |
0.2 | 0.4 | GO:0060711 | labyrinthine layer development(GO:0060711) |
0.2 | 5.3 | GO:0030048 | actin filament-based movement(GO:0030048) |
0.2 | 0.2 | GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway(GO:0007178) |
0.2 | 0.6 | GO:0042593 | carbohydrate homeostasis(GO:0033500) glucose homeostasis(GO:0042593) |
0.2 | 0.4 | GO:0007398 | ectoderm development(GO:0007398) |
0.2 | 0.6 | GO:0010595 | positive regulation of endothelial cell migration(GO:0010595) |
0.2 | 1.9 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.2 | 0.2 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.2 | 2.2 | GO:0043687 | post-translational protein modification(GO:0043687) |
0.2 | 10.5 | GO:0006869 | lipid transport(GO:0006869) |
0.2 | 0.6 | GO:0010043 | response to zinc ion(GO:0010043) |
0.2 | 204.1 | GO:0016070 | RNA metabolic process(GO:0016070) |
0.2 | 0.4 | GO:0007569 | cell aging(GO:0007569) |
0.2 | 0.5 | GO:0007340 | acrosome reaction(GO:0007340) |
0.2 | 0.5 | GO:0021766 | hippocampus development(GO:0021766) |
0.2 | 0.2 | GO:0015840 | urea transport(GO:0015840) |
0.2 | 0.7 | GO:0006091 | generation of precursor metabolites and energy(GO:0006091) |
0.2 | 31.2 | GO:0006915 | apoptotic process(GO:0006915) |
0.2 | 0.2 | GO:0032880 | regulation of protein localization(GO:0032880) |
0.2 | 0.3 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.2 | 0.2 | GO:0048534 | hematopoietic or lymphoid organ development(GO:0048534) |
0.2 | 0.9 | GO:0019221 | cytokine-mediated signaling pathway(GO:0019221) |
0.2 | 0.3 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.2 | 1.5 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.2 | 0.3 | GO:0035050 | embryonic heart tube development(GO:0035050) |
0.2 | 3.8 | GO:0050900 | leukocyte migration(GO:0050900) |
0.1 | 0.1 | GO:0030856 | regulation of epithelial cell differentiation(GO:0030856) |
0.1 | 0.1 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.1 | 1.6 | GO:0010038 | response to metal ion(GO:0010038) |
0.1 | 0.1 | GO:0001658 | branching involved in ureteric bud morphogenesis(GO:0001658) |
0.1 | 0.4 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.1 | 0.1 | GO:0044257 | cellular protein catabolic process(GO:0044257) |
0.1 | 39.7 | GO:0006508 | proteolysis(GO:0006508) |
0.1 | 0.5 | GO:0040014 | regulation of multicellular organism growth(GO:0040014) |
0.1 | 2.2 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.1 | 3.1 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.1 | 0.4 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.1 | 0.1 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.1 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.5 | GO:0009072 | aromatic amino acid family metabolic process(GO:0009072) |
0.1 | 0.1 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.1 | 0.1 | GO:0030826 | cGMP-mediated signaling(GO:0019934) regulation of cGMP biosynthetic process(GO:0030826) |
0.1 | 0.3 | GO:0007498 | mesoderm development(GO:0007498) |
0.1 | 0.1 | GO:0009251 | glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.1 | 0.4 | GO:0060041 | retina development in camera-type eye(GO:0060041) |
0.1 | 1.4 | GO:0060271 | cilium morphogenesis(GO:0060271) |
0.1 | 0.1 | GO:0032094 | response to food(GO:0032094) |
0.1 | 0.1 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.1 | 0.1 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.1 | 17.3 | GO:0055114 | oxidation-reduction process(GO:0055114) |
0.1 | 0.1 | GO:0097435 | extracellular fibril organization(GO:0043206) fibril organization(GO:0097435) |
0.1 | 0.2 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.1 | 0.2 | GO:0030277 | epithelial structure maintenance(GO:0010669) maintenance of gastrointestinal epithelium(GO:0030277) |
0.1 | 0.2 | GO:0042446 | hormone biosynthetic process(GO:0042446) |
0.1 | 0.3 | GO:0030278 | regulation of ossification(GO:0030278) |
0.1 | 0.1 | GO:0043297 | apical junction assembly(GO:0043297) |
0.1 | 0.4 | GO:0050427 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.1 | 0.1 | GO:0098743 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.1 | 0.1 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.0 | 0.3 | GO:0042552 | myelination(GO:0042552) |
0.0 | 0.0 | GO:0072330 | monocarboxylic acid biosynthetic process(GO:0072330) |
0.0 | 0.0 | GO:0034446 | substrate adhesion-dependent cell spreading(GO:0034446) |
0.0 | 0.6 | GO:0008277 | regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
0.0 | 0.3 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
0.0 | 0.3 | GO:0009063 | cellular amino acid catabolic process(GO:0009063) |
0.0 | 0.0 | GO:0051276 | chromosome organization(GO:0051276) |
0.0 | 0.5 | GO:0043269 | regulation of ion transport(GO:0043269) |
0.0 | 0.1 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.0 | GO:0006942 | regulation of striated muscle contraction(GO:0006942) |
0.0 | 0.1 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.7 | GO:0009410 | response to xenobiotic stimulus(GO:0009410) |
0.0 | 0.0 | GO:0072009 | renal tubule development(GO:0061326) nephron epithelium development(GO:0072009) nephron tubule development(GO:0072080) |
0.0 | 0.0 | GO:0018205 | peptidyl-lysine modification(GO:0018205) |
0.0 | 0.1 | GO:0050892 | intestinal absorption(GO:0050892) |
0.0 | 0.0 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 | 0.4 | GO:0046907 | intracellular transport(GO:0046907) |
0.0 | 0.1 | GO:0009855 | determination of bilateral symmetry(GO:0009855) |
0.0 | 0.0 | GO:0007260 | tyrosine phosphorylation of STAT protein(GO:0007260) |
0.0 | 6.3 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.0 | GO:0060052 | intermediate filament bundle assembly(GO:0045110) neurofilament cytoskeleton organization(GO:0060052) |
0.0 | 0.0 | GO:0045471 | response to ethanol(GO:0045471) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.3 | 16.0 | GO:0072487 | MSL complex(GO:0072487) |
5.2 | 20.8 | GO:0070820 | tertiary granule(GO:0070820) |
5.2 | 20.7 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
4.7 | 18.9 | GO:0005827 | polar microtubule(GO:0005827) |
4.2 | 25.1 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
4.1 | 12.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
3.6 | 14.5 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
3.5 | 10.4 | GO:0000124 | SAGA complex(GO:0000124) |
3.4 | 10.2 | GO:1903561 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
3.2 | 9.5 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
3.2 | 9.5 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
3.1 | 3.1 | GO:0070938 | contractile ring(GO:0070938) |
3.0 | 11.9 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
3.0 | 11.9 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
2.9 | 26.4 | GO:0042555 | MCM complex(GO:0042555) |
2.9 | 11.5 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
2.8 | 22.6 | GO:0048786 | presynaptic active zone(GO:0048786) |
2.7 | 13.7 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
2.7 | 8.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
2.6 | 31.8 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
2.6 | 7.8 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
2.6 | 13.0 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
2.6 | 15.5 | GO:0042382 | paraspeckles(GO:0042382) |
2.6 | 43.5 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
2.5 | 10.0 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
2.4 | 29.1 | GO:0001772 | immunological synapse(GO:0001772) |
2.3 | 9.3 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
2.3 | 6.9 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
2.3 | 13.8 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
2.3 | 6.8 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
2.3 | 18.1 | GO:0071564 | npBAF complex(GO:0071564) |
2.3 | 6.8 | GO:0032009 | early phagosome(GO:0032009) |
2.2 | 15.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
2.2 | 4.4 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
2.2 | 17.7 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
2.2 | 30.7 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
2.2 | 4.3 | GO:0044462 | external encapsulating structure part(GO:0044462) |
2.2 | 43.1 | GO:0031519 | PcG protein complex(GO:0031519) |
2.1 | 4.2 | GO:0042575 | DNA polymerase complex(GO:0042575) |
2.1 | 2.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
2.1 | 12.7 | GO:0070688 | MLL5-L complex(GO:0070688) |
2.1 | 4.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
2.1 | 2.1 | GO:0031090 | organelle membrane(GO:0031090) |
2.1 | 8.3 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
2.1 | 4.1 | GO:0031932 | TORC2 complex(GO:0031932) |
2.0 | 10.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
2.0 | 12.1 | GO:0051233 | spindle midzone(GO:0051233) |
2.0 | 12.0 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
2.0 | 16.0 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
2.0 | 14.0 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
2.0 | 5.9 | GO:0042405 | nuclear inclusion body(GO:0042405) |
2.0 | 7.9 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
1.9 | 9.6 | GO:0070822 | Sin3 complex(GO:0016580) Sin3-type complex(GO:0070822) |
1.9 | 5.6 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
1.9 | 5.6 | GO:0008537 | proteasome activator complex(GO:0008537) |
1.9 | 13.0 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
1.8 | 5.5 | GO:0030891 | VCB complex(GO:0030891) |
1.8 | 16.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
1.8 | 1.8 | GO:0030686 | 90S preribosome(GO:0030686) |
1.8 | 7.2 | GO:0016589 | NURF complex(GO:0016589) |
1.8 | 1.8 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
1.8 | 41.2 | GO:0097610 | cell division site(GO:0032153) cleavage furrow(GO:0032154) cell division site part(GO:0032155) cell surface furrow(GO:0097610) |
1.8 | 66.0 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
1.8 | 17.8 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
1.8 | 5.3 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
1.8 | 8.8 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
1.7 | 8.7 | GO:0016514 | SWI/SNF complex(GO:0016514) |
1.7 | 3.5 | GO:0015935 | small ribosomal subunit(GO:0015935) |
1.7 | 1.7 | GO:0070852 | cell body fiber(GO:0070852) |
1.7 | 3.4 | GO:0031010 | ISWI-type complex(GO:0031010) |
1.7 | 11.9 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
1.7 | 112.5 | GO:0005643 | nuclear pore(GO:0005643) |
1.7 | 15.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
1.7 | 1.7 | GO:0045178 | basal part of cell(GO:0045178) |
1.7 | 15.1 | GO:0042101 | T cell receptor complex(GO:0042101) |
1.7 | 8.4 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
1.7 | 3.3 | GO:0038201 | TOR complex(GO:0038201) |
1.7 | 6.6 | GO:0005638 | lamin filament(GO:0005638) |
1.6 | 34.5 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
1.6 | 4.9 | GO:0005828 | kinetochore microtubule(GO:0005828) |
1.6 | 8.1 | GO:0070695 | FHF complex(GO:0070695) |
1.6 | 161.1 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
1.6 | 87.8 | GO:0016605 | PML body(GO:0016605) |
1.6 | 29.1 | GO:0031201 | SNARE complex(GO:0031201) |
1.6 | 4.8 | GO:0032059 | bleb(GO:0032059) |
1.6 | 4.8 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
1.6 | 19.0 | GO:0032039 | integrator complex(GO:0032039) |
1.6 | 4.7 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
1.6 | 4.7 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
1.6 | 26.9 | GO:0032420 | stereocilium(GO:0032420) |
1.6 | 7.8 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
1.6 | 7.8 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
1.6 | 7.8 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
1.6 | 23.4 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
1.6 | 14.0 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
1.6 | 9.3 | GO:0005682 | U5 snRNP(GO:0005682) |
1.6 | 1.6 | GO:0042641 | actomyosin(GO:0042641) |
1.5 | 7.7 | GO:0000792 | heterochromatin(GO:0000792) |
1.5 | 7.7 | GO:0005677 | chromatin silencing complex(GO:0005677) |
1.5 | 13.8 | GO:0022624 | proteasome regulatory particle(GO:0005838) proteasome accessory complex(GO:0022624) |
1.5 | 12.2 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
1.5 | 18.3 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
1.5 | 4.5 | GO:0005884 | actin filament(GO:0005884) |
1.5 | 4.5 | GO:0031312 | extrinsic component of organelle membrane(GO:0031312) |
1.5 | 11.9 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
1.5 | 45.6 | GO:0016592 | mediator complex(GO:0016592) |
1.5 | 49.5 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
1.4 | 2.9 | GO:0070552 | BRISC complex(GO:0070552) |
1.4 | 4.3 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
1.4 | 15.9 | GO:0035631 | CD40 receptor complex(GO:0035631) |
1.4 | 1.4 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
1.4 | 8.4 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) |
1.4 | 2.8 | GO:0005902 | microvillus(GO:0005902) |
1.4 | 12.5 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
1.4 | 8.3 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
1.4 | 9.7 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
1.4 | 5.5 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
1.4 | 5.5 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
1.4 | 17.8 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
1.4 | 6.8 | GO:0031332 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
1.4 | 4.1 | GO:0005876 | spindle microtubule(GO:0005876) |
1.4 | 4.1 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
1.4 | 4.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
1.3 | 10.8 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
1.3 | 4.0 | GO:0031904 | endosome lumen(GO:0031904) |
1.3 | 21.3 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
1.3 | 4.0 | GO:0002080 | acrosomal membrane(GO:0002080) |
1.3 | 3.9 | GO:0071817 | MMXD complex(GO:0071817) |
1.3 | 1.3 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) |
1.3 | 5.2 | GO:0000791 | euchromatin(GO:0000791) |
1.3 | 5.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
1.3 | 104.1 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
1.3 | 62.7 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
1.3 | 59.8 | GO:0000922 | spindle pole(GO:0000922) |
1.3 | 12.7 | GO:0005844 | polysome(GO:0005844) |
1.3 | 15.1 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
1.3 | 11.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
1.3 | 16.4 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
1.2 | 36.2 | GO:0042645 | mitochondrial nucleoid(GO:0042645) |
1.2 | 26.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
1.2 | 7.5 | GO:0034464 | BBSome(GO:0034464) |
1.2 | 14.9 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
1.2 | 11.1 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
1.2 | 53.1 | GO:0055037 | recycling endosome(GO:0055037) |
1.2 | 4.9 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
1.2 | 3.7 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
1.2 | 4.9 | GO:0016600 | flotillin complex(GO:0016600) |
1.2 | 9.8 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
1.2 | 3.7 | GO:0001652 | granular component(GO:0001652) |
1.2 | 25.4 | GO:0035097 | methyltransferase complex(GO:0034708) histone methyltransferase complex(GO:0035097) |
1.2 | 56.7 | GO:0000790 | nuclear chromatin(GO:0000790) |
1.2 | 6.0 | GO:0000346 | transcription export complex(GO:0000346) |
1.2 | 16.8 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
1.2 | 20.3 | GO:0005871 | kinesin complex(GO:0005871) |
1.2 | 4.8 | GO:0000300 | obsolete peripheral to membrane of membrane fraction(GO:0000300) |
1.2 | 118.5 | GO:0016607 | nuclear speck(GO:0016607) |
1.2 | 2.4 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
1.2 | 10.6 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
1.2 | 5.9 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
1.2 | 3.5 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
1.2 | 11.7 | GO:0030914 | STAGA complex(GO:0030914) |
1.2 | 2.3 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
1.2 | 1.2 | GO:0000800 | lateral element(GO:0000800) |
1.2 | 3.5 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
1.2 | 8.1 | GO:0000145 | exocyst(GO:0000145) |
1.2 | 4.6 | GO:0045281 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
1.2 | 45.0 | GO:0000502 | proteasome complex(GO:0000502) |
1.2 | 2.3 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
1.1 | 33.3 | GO:0030496 | midbody(GO:0030496) |
1.1 | 6.8 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
1.1 | 3.4 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
1.1 | 111.7 | GO:0005769 | early endosome(GO:0005769) |
1.1 | 5.6 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
1.1 | 9.0 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
1.1 | 4.5 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
1.1 | 6.7 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
1.1 | 2.2 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
1.1 | 5.6 | GO:0000796 | condensin complex(GO:0000796) |
1.1 | 4.4 | GO:0005869 | dynactin complex(GO:0005869) |
1.1 | 1.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
1.1 | 39.4 | GO:0000776 | kinetochore(GO:0000776) |
1.1 | 6.6 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
1.1 | 5.4 | GO:0042589 | zymogen granule membrane(GO:0042589) |
1.1 | 88.5 | GO:0005681 | spliceosomal complex(GO:0005681) |
1.1 | 31.2 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
1.1 | 9.7 | GO:0017119 | Golgi transport complex(GO:0017119) |
1.1 | 96.4 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
1.1 | 25.4 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
1.1 | 119.6 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
1.1 | 4.2 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
1.0 | 3.1 | GO:0001950 | obsolete plasma membrane enriched fraction(GO:0001950) |
1.0 | 7.3 | GO:0000123 | histone acetyltransferase complex(GO:0000123) protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
1.0 | 14.5 | GO:0005637 | nuclear inner membrane(GO:0005637) |
1.0 | 5.2 | GO:0005883 | neurofilament(GO:0005883) |
1.0 | 45.2 | GO:0031228 | intrinsic component of Golgi membrane(GO:0031228) |
1.0 | 5.1 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.0 | 110.8 | GO:0000785 | chromatin(GO:0000785) |
1.0 | 51.2 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
1.0 | 26.6 | GO:0016363 | nuclear matrix(GO:0016363) |
1.0 | 31.6 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
1.0 | 457.5 | GO:0005654 | nucleoplasm(GO:0005654) |
1.0 | 4.1 | GO:0017059 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
1.0 | 13.2 | GO:0000118 | histone deacetylase complex(GO:0000118) |
1.0 | 5.0 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
1.0 | 22.1 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
1.0 | 2.0 | GO:0042584 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
1.0 | 34.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
1.0 | 2.9 | GO:0005899 | insulin receptor complex(GO:0005899) |
1.0 | 22.5 | GO:0031902 | late endosome membrane(GO:0031902) |
1.0 | 4.9 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
1.0 | 1.9 | GO:0070531 | BRCA1-A complex(GO:0070531) |
1.0 | 1.0 | GO:0045298 | tubulin complex(GO:0045298) |
1.0 | 47.2 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.9 | 22.5 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.9 | 4.7 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.9 | 20.5 | GO:0005819 | spindle(GO:0005819) |
0.9 | 14.0 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.9 | 7.4 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.9 | 2.8 | GO:0042588 | zymogen granule(GO:0042588) |
0.9 | 2.8 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.9 | 8.3 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
0.9 | 53.4 | GO:0031965 | nuclear membrane(GO:0031965) |
0.9 | 20.1 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.9 | 33.9 | GO:0005747 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.9 | 13.7 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.9 | 2.7 | GO:0098573 | intrinsic component of mitochondrial membrane(GO:0098573) |
0.9 | 2.7 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.9 | 7.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.9 | 4.5 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.9 | 6.3 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.9 | 2.7 | GO:0030893 | cohesin complex(GO:0008278) meiotic cohesin complex(GO:0030893) |
0.9 | 19.6 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.9 | 3.5 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.9 | 2.7 | GO:0045120 | pronucleus(GO:0045120) |
0.9 | 0.9 | GO:0030120 | vesicle coat(GO:0030120) |
0.9 | 9.4 | GO:0005624 | obsolete membrane fraction(GO:0005624) |
0.9 | 100.1 | GO:0005813 | centrosome(GO:0005813) |
0.9 | 5.1 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) ATPase complex(GO:1904949) |
0.8 | 3.4 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.8 | 120.3 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.8 | 15.9 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.8 | 3.3 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.8 | 488.4 | GO:0005730 | nucleolus(GO:0005730) |
0.8 | 864.6 | GO:0005829 | cytosol(GO:0005829) |
0.8 | 1.6 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.8 | 29.4 | GO:0005840 | ribosome(GO:0005840) |
0.8 | 2.5 | GO:0048179 | activin receptor complex(GO:0048179) |
0.8 | 132.8 | GO:0031966 | mitochondrial membrane(GO:0031966) |
0.8 | 0.8 | GO:0001741 | XY body(GO:0001741) |
0.8 | 1.6 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.8 | 2.3 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.8 | 11.5 | GO:0019861 | obsolete flagellum(GO:0019861) |
0.8 | 9.1 | GO:0030665 | clathrin-coated vesicle membrane(GO:0030665) |
0.8 | 3.8 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.8 | 18.9 | GO:0008305 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
0.8 | 4.5 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.7 | 3.7 | GO:0002102 | podosome(GO:0002102) |
0.7 | 4.5 | GO:0016234 | inclusion body(GO:0016234) |
0.7 | 0.7 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.7 | 5.1 | GO:0005776 | autophagosome(GO:0005776) |
0.7 | 1.5 | GO:0001891 | phagocytic cup(GO:0001891) |
0.7 | 246.2 | GO:0005739 | mitochondrion(GO:0005739) |
0.7 | 33.6 | GO:0005694 | chromosome(GO:0005694) |
0.7 | 1.4 | GO:0043204 | perikaryon(GO:0043204) |
0.7 | 4.9 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.7 | 1.4 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.7 | 1.4 | GO:0032590 | dendrite membrane(GO:0032590) |
0.7 | 1.4 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.7 | 1.3 | GO:0032432 | actin filament bundle(GO:0032432) |
0.7 | 2.0 | GO:0001673 | male germ cell nucleus(GO:0001673) germ cell nucleus(GO:0043073) |
0.7 | 21.3 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.7 | 11.9 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.7 | 4.0 | GO:0016272 | prefoldin complex(GO:0016272) |
0.7 | 25.6 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.6 | 11.0 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.6 | 239.6 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.6 | 98.4 | GO:0000139 | Golgi membrane(GO:0000139) |
0.6 | 1409.7 | GO:0005634 | nucleus(GO:0005634) |
0.6 | 5.6 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.6 | 1.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.6 | 0.6 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.6 | 12.1 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.6 | 5.3 | GO:0030057 | desmosome(GO:0030057) |
0.6 | 1.1 | GO:0042599 | lamellar body(GO:0042599) |
0.6 | 30.0 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.5 | 2.2 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
0.5 | 1.6 | GO:0043679 | axon terminus(GO:0043679) |
0.5 | 0.5 | GO:1902554 | serine/threonine protein kinase complex(GO:1902554) |
0.5 | 1.6 | GO:0071203 | WASH complex(GO:0071203) |
0.5 | 4.8 | GO:0031514 | motile cilium(GO:0031514) |
0.5 | 13.6 | GO:0016459 | myosin complex(GO:0016459) |
0.5 | 3.2 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
0.4 | 15.1 | GO:0098802 | plasma membrane receptor complex(GO:0098802) |
0.4 | 0.8 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.4 | 39.1 | GO:0015630 | microtubule cytoskeleton(GO:0015630) |
0.4 | 16.2 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.4 | 0.4 | GO:0005915 | zonula adherens(GO:0005915) |
0.4 | 5.0 | GO:0072372 | primary cilium(GO:0072372) |
0.4 | 0.8 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) cytoplasmic side of membrane(GO:0098562) |
0.4 | 1.5 | GO:0005667 | transcription factor complex(GO:0005667) |
0.4 | 1.1 | GO:0060170 | ciliary membrane(GO:0060170) |
0.4 | 18.5 | GO:0098552 | side of membrane(GO:0098552) |
0.4 | 1.8 | GO:0005811 | lipid particle(GO:0005811) |
0.4 | 53.5 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.4 | 13.7 | GO:0005768 | endosome(GO:0005768) |
0.3 | 0.3 | GO:0030684 | preribosome(GO:0030684) |
0.3 | 1.3 | GO:0033011 | perinuclear theca(GO:0033011) |
0.3 | 0.9 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.3 | 6.4 | GO:0005921 | gap junction(GO:0005921) |
0.3 | 0.6 | GO:0043198 | dendritic shaft(GO:0043198) |
0.3 | 1.3 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.3 | 0.3 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.3 | 0.5 | GO:0098794 | postsynapse(GO:0098794) |
0.2 | 0.7 | GO:1902494 | catalytic complex(GO:1902494) |
0.2 | 2.3 | GO:0043195 | terminal bouton(GO:0043195) |
0.2 | 0.6 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.2 | 384.1 | GO:0005622 | intracellular(GO:0005622) |
0.2 | 0.8 | GO:0001533 | cornified envelope(GO:0001533) |
0.2 | 0.4 | GO:0019867 | outer membrane(GO:0019867) |
0.2 | 0.2 | GO:0014704 | cell-cell adherens junction(GO:0005913) intercalated disc(GO:0014704) cell-cell contact zone(GO:0044291) |
0.1 | 0.1 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 221.8 | GO:0016021 | integral component of membrane(GO:0016021) |
0.0 | 0.2 | GO:0005929 | cilium(GO:0005929) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.3 | 15.8 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
4.9 | 14.8 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
4.0 | 12.0 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
4.0 | 16.0 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
3.9 | 7.8 | GO:0070061 | fructose binding(GO:0070061) |
3.9 | 23.5 | GO:0005521 | lamin binding(GO:0005521) |
3.7 | 11.1 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
3.6 | 18.0 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
3.6 | 10.8 | GO:0070644 | vitamin D response element binding(GO:0070644) |
3.6 | 10.8 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
3.5 | 14.1 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
3.4 | 10.1 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
3.4 | 10.1 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
3.4 | 13.5 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
3.2 | 9.6 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
3.2 | 19.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
3.2 | 9.5 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
3.2 | 9.5 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
3.2 | 9.5 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate phosphatase activity(GO:0052834) |
3.1 | 18.5 | GO:0001727 | lipid kinase activity(GO:0001727) |
3.0 | 3.0 | GO:0016705 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen(GO:0016705) |
3.0 | 14.8 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
3.0 | 23.6 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
2.9 | 8.8 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
2.9 | 11.5 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
2.8 | 11.3 | GO:0035173 | histone kinase activity(GO:0035173) |
2.8 | 8.4 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
2.7 | 10.9 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
2.7 | 24.3 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
2.6 | 21.1 | GO:0005522 | profilin binding(GO:0005522) |
2.6 | 15.4 | GO:0015288 | porin activity(GO:0015288) |
2.5 | 7.6 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
2.5 | 2.5 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
2.5 | 7.5 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
2.5 | 9.9 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
2.5 | 2.5 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
2.5 | 7.5 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
2.5 | 24.6 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
2.5 | 17.2 | GO:0008494 | translation activator activity(GO:0008494) |
2.4 | 4.9 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
2.4 | 19.5 | GO:0019992 | diacylglycerol binding(GO:0019992) |
2.4 | 7.3 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
2.4 | 7.1 | GO:0051425 | PTB domain binding(GO:0051425) |
2.4 | 28.3 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) |
2.4 | 9.4 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
2.3 | 2.3 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
2.3 | 2.3 | GO:0035591 | signaling adaptor activity(GO:0035591) |
2.3 | 9.2 | GO:0043495 | protein anchor(GO:0043495) |
2.3 | 20.8 | GO:0008536 | Ran GTPase binding(GO:0008536) |
2.3 | 2.3 | GO:0035197 | siRNA binding(GO:0035197) |
2.3 | 38.9 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
2.3 | 4.6 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
2.3 | 13.7 | GO:0051400 | BH domain binding(GO:0051400) |
2.3 | 6.8 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
2.3 | 9.1 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
2.3 | 4.5 | GO:0004969 | histamine receptor activity(GO:0004969) |
2.3 | 6.8 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
2.3 | 6.8 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
2.2 | 9.0 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
2.2 | 6.6 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
2.2 | 8.8 | GO:0004849 | uridine kinase activity(GO:0004849) |
2.2 | 6.6 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
2.2 | 11.0 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
2.2 | 13.0 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
2.2 | 10.8 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
2.2 | 15.1 | GO:0042805 | actinin binding(GO:0042805) |
2.1 | 2.1 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
2.1 | 8.5 | GO:0030911 | TPR domain binding(GO:0030911) |
2.1 | 6.3 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
2.1 | 8.4 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
2.1 | 12.6 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
2.1 | 14.7 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
2.1 | 18.8 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
2.1 | 37.4 | GO:0043621 | protein self-association(GO:0043621) |
2.1 | 2.1 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
2.1 | 6.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
2.1 | 14.4 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
2.1 | 10.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
2.0 | 6.1 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
2.0 | 6.1 | GO:0043398 | HLH domain binding(GO:0043398) |
2.0 | 10.1 | GO:0034452 | dynactin binding(GO:0034452) |
2.0 | 4.0 | GO:0032452 | histone demethylase activity(GO:0032452) |
2.0 | 13.9 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
2.0 | 6.0 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
2.0 | 13.9 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
2.0 | 7.9 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
2.0 | 2.0 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
2.0 | 2.0 | GO:0016896 | exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
2.0 | 11.7 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
1.9 | 15.5 | GO:0050700 | CARD domain binding(GO:0050700) |
1.9 | 1.9 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
1.9 | 5.8 | GO:0001849 | complement component C1q binding(GO:0001849) |
1.9 | 9.6 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
1.9 | 5.7 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
1.9 | 13.3 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
1.9 | 7.6 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
1.9 | 9.5 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
1.9 | 7.6 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
1.9 | 28.3 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
1.9 | 5.7 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
1.9 | 13.2 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
1.9 | 18.7 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
1.9 | 9.3 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
1.9 | 9.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
1.9 | 7.4 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
1.9 | 7.4 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
1.9 | 5.6 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
1.9 | 9.3 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
1.8 | 14.8 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
1.8 | 1.8 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
1.8 | 1.8 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
1.8 | 7.2 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
1.8 | 16.2 | GO:0070412 | R-SMAD binding(GO:0070412) |
1.8 | 9.0 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
1.8 | 3.6 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
1.8 | 7.2 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
1.8 | 8.9 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
1.8 | 5.3 | GO:0042608 | T cell receptor binding(GO:0042608) |
1.8 | 10.7 | GO:0030507 | spectrin binding(GO:0030507) |
1.8 | 5.3 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
1.8 | 5.3 | GO:0004428 | obsolete inositol or phosphatidylinositol kinase activity(GO:0004428) |
1.8 | 5.3 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
1.8 | 31.7 | GO:0048487 | beta-tubulin binding(GO:0048487) |
1.8 | 7.0 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
1.8 | 1.8 | GO:0005534 | galactose binding(GO:0005534) |
1.8 | 10.6 | GO:0030274 | LIM domain binding(GO:0030274) |
1.8 | 10.5 | GO:0003678 | DNA helicase activity(GO:0003678) |
1.8 | 5.3 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
1.7 | 12.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
1.7 | 12.2 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
1.7 | 15.7 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
1.7 | 8.7 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
1.7 | 24.3 | GO:0051059 | NF-kappaB binding(GO:0051059) |
1.7 | 34.4 | GO:0008186 | RNA-dependent ATPase activity(GO:0008186) |
1.7 | 8.6 | GO:0019789 | SUMO transferase activity(GO:0019789) |
1.7 | 1.7 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
1.7 | 41.0 | GO:0002039 | p53 binding(GO:0002039) |
1.7 | 3.4 | GO:0016803 | ether hydrolase activity(GO:0016803) |
1.7 | 5.1 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
1.7 | 15.3 | GO:0005112 | Notch binding(GO:0005112) |
1.7 | 27.1 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
1.7 | 1.7 | GO:0004532 | exoribonuclease activity(GO:0004532) |
1.7 | 18.5 | GO:0030275 | LRR domain binding(GO:0030275) |
1.7 | 1.7 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
1.7 | 6.7 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
1.7 | 30.1 | GO:0050699 | WW domain binding(GO:0050699) |
1.7 | 5.0 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
1.7 | 13.2 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
1.6 | 47.6 | GO:0016279 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
1.6 | 4.9 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
1.6 | 4.9 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
1.6 | 16.3 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
1.6 | 8.2 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
1.6 | 6.5 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
1.6 | 66.5 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
1.6 | 4.8 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
1.6 | 3.2 | GO:0005113 | patched binding(GO:0005113) |
1.6 | 6.4 | GO:0050815 | phosphoserine binding(GO:0050815) |
1.6 | 64.1 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
1.6 | 1.6 | GO:0000404 | heteroduplex DNA loop binding(GO:0000404) |
1.6 | 31.9 | GO:0003682 | chromatin binding(GO:0003682) |
1.6 | 6.4 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
1.6 | 4.8 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
1.6 | 4.7 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
1.6 | 4.7 | GO:0047894 | flavonol 3-sulfotransferase activity(GO:0047894) |
1.6 | 4.7 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.6 | 3.1 | GO:0003917 | DNA topoisomerase activity(GO:0003916) DNA topoisomerase type I activity(GO:0003917) |
1.6 | 9.4 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
1.6 | 4.7 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
1.6 | 12.4 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
1.6 | 6.2 | GO:0017070 | U6 snRNA binding(GO:0017070) |
1.5 | 1.5 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
1.5 | 131.5 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
1.5 | 3.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
1.5 | 7.7 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
1.5 | 21.5 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
1.5 | 7.7 | GO:0017069 | snRNA binding(GO:0017069) |
1.5 | 4.6 | GO:0016842 | amidine-lyase activity(GO:0016842) |
1.5 | 9.1 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
1.5 | 1.5 | GO:0034595 | phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
1.5 | 6.1 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
1.5 | 6.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
1.5 | 7.6 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
1.5 | 52.9 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
1.5 | 3.0 | GO:0005035 | death receptor activity(GO:0005035) |
1.5 | 10.5 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
1.5 | 1.5 | GO:0034618 | arginine binding(GO:0034618) |
1.5 | 4.5 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
1.5 | 1.5 | GO:0051998 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
1.5 | 6.0 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
1.5 | 3.0 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
1.5 | 10.4 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
1.5 | 4.5 | GO:0016972 | thiol oxidase activity(GO:0016972) |
1.5 | 19.4 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
1.5 | 7.4 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
1.5 | 1.5 | GO:0031491 | nucleosome binding(GO:0031491) |
1.5 | 8.9 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
1.5 | 8.9 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
1.5 | 4.4 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
1.5 | 42.8 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
1.5 | 19.2 | GO:0031593 | polyubiquitin binding(GO:0031593) |
1.5 | 5.9 | GO:0030276 | clathrin binding(GO:0030276) |
1.5 | 8.8 | GO:0003688 | DNA replication origin binding(GO:0003688) |
1.5 | 10.3 | GO:0030332 | cyclin binding(GO:0030332) |
1.5 | 39.6 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
1.5 | 70.3 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
1.5 | 17.5 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
1.5 | 4.4 | GO:0008327 | methyl-CpG binding(GO:0008327) |
1.5 | 5.8 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
1.4 | 24.6 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
1.4 | 10.1 | GO:0003724 | RNA helicase activity(GO:0003724) |
1.4 | 4.3 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
1.4 | 4.3 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
1.4 | 5.7 | GO:0004340 | glucokinase activity(GO:0004340) |
1.4 | 17.2 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
1.4 | 8.6 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
1.4 | 4.3 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
1.4 | 4.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
1.4 | 4.3 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
1.4 | 1.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
1.4 | 11.2 | GO:0030371 | translation repressor activity(GO:0030371) |
1.4 | 14.0 | GO:0004697 | protein kinase C activity(GO:0004697) |
1.4 | 11.2 | GO:0001671 | ATPase activator activity(GO:0001671) |
1.4 | 9.8 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
1.4 | 5.6 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
1.4 | 5.6 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
1.4 | 11.1 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
1.4 | 5.6 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
1.4 | 15.3 | GO:0017091 | AU-rich element binding(GO:0017091) |
1.4 | 16.6 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
1.4 | 20.7 | GO:0035064 | methylated histone binding(GO:0035064) |
1.4 | 19.4 | GO:0043498 | obsolete cell surface binding(GO:0043498) |
1.4 | 9.7 | GO:0000339 | RNA cap binding(GO:0000339) |
1.4 | 1.4 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
1.4 | 6.8 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
1.4 | 40.9 | GO:0015179 | L-amino acid transmembrane transporter activity(GO:0015179) |
1.4 | 6.8 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
1.4 | 8.1 | GO:0050733 | RS domain binding(GO:0050733) |
1.4 | 8.1 | GO:0009922 | fatty acid elongase activity(GO:0009922) |
1.4 | 2.7 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
1.3 | 4.0 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
1.3 | 14.8 | GO:0010181 | FMN binding(GO:0010181) |
1.3 | 9.4 | GO:0004568 | chitinase activity(GO:0004568) |
1.3 | 10.8 | GO:0017049 | GTP-Rho binding(GO:0017049) |
1.3 | 16.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
1.3 | 8.0 | GO:0070402 | NADPH binding(GO:0070402) |
1.3 | 5.3 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
1.3 | 2.6 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
1.3 | 14.5 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
1.3 | 5.3 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
1.3 | 39.4 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
1.3 | 1.3 | GO:0043028 | cysteine-type endopeptidase regulator activity involved in apoptotic process(GO:0043028) |
1.3 | 11.7 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
1.3 | 3.9 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
1.3 | 29.8 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
1.3 | 3.9 | GO:0045569 | TRAIL binding(GO:0045569) |
1.3 | 3.9 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
1.3 | 5.2 | GO:0031014 | troponin T binding(GO:0031014) |
1.3 | 1.3 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
1.3 | 12.9 | GO:0008199 | ferric iron binding(GO:0008199) |
1.3 | 3.9 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
1.3 | 3.8 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
1.3 | 10.1 | GO:0017025 | TBP-class protein binding(GO:0017025) |
1.3 | 3.8 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.3 | 7.5 | GO:0016208 | AMP binding(GO:0016208) |
1.3 | 13.8 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
1.2 | 5.0 | GO:0015925 | galactosidase activity(GO:0015925) |
1.2 | 1.2 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
1.2 | 4.9 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
1.2 | 7.4 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
1.2 | 28.3 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
1.2 | 2.5 | GO:0070063 | RNA polymerase binding(GO:0070063) |
1.2 | 23.2 | GO:0005484 | SNAP receptor activity(GO:0005484) |
1.2 | 4.9 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
1.2 | 3.6 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
1.2 | 1.2 | GO:0016362 | activin receptor activity, type II(GO:0016362) |
1.2 | 4.8 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
1.2 | 2.4 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
1.2 | 8.4 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
1.2 | 6.0 | GO:0004904 | interferon receptor activity(GO:0004904) |
1.2 | 4.8 | GO:0046979 | TAP binding(GO:0046977) TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
1.2 | 3.6 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
1.2 | 3.6 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
1.2 | 8.3 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
1.2 | 85.1 | GO:0008565 | protein transporter activity(GO:0008565) |
1.2 | 9.5 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
1.2 | 1.2 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
1.2 | 3.5 | GO:0043515 | kinetochore binding(GO:0043515) |
1.2 | 8.2 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
1.2 | 4.7 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
1.2 | 16.4 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
1.2 | 8.2 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
1.2 | 1.2 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
1.2 | 7.0 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
1.2 | 2.3 | GO:0015205 | nucleobase transmembrane transporter activity(GO:0015205) |
1.2 | 4.6 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
1.2 | 5.8 | GO:0031685 | adenosine receptor binding(GO:0031685) |
1.2 | 2.3 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
1.2 | 3.5 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
1.2 | 8.1 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
1.1 | 4.6 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
1.1 | 1.1 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
1.1 | 52.8 | GO:0003743 | translation initiation factor activity(GO:0003743) |
1.1 | 1.1 | GO:0070410 | co-SMAD binding(GO:0070410) |
1.1 | 6.9 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
1.1 | 30.8 | GO:0034061 | DNA polymerase activity(GO:0034061) |
1.1 | 2.3 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
1.1 | 5.7 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
1.1 | 12.4 | GO:0016251 | obsolete general RNA polymerase II transcription factor activity(GO:0016251) |
1.1 | 1.1 | GO:0004875 | complement receptor activity(GO:0004875) |
1.1 | 51.7 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) ubiquitin-like protein ligase binding(GO:0044389) |
1.1 | 6.7 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
1.1 | 14.5 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
1.1 | 37.9 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
1.1 | 13.3 | GO:0005048 | signal sequence binding(GO:0005048) |
1.1 | 23.3 | GO:0019003 | GDP binding(GO:0019003) |
1.1 | 12.2 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
1.1 | 145.1 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
1.1 | 13.3 | GO:0070888 | E-box binding(GO:0070888) |
1.1 | 35.4 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
1.1 | 2.2 | GO:0016530 | metallochaperone activity(GO:0016530) copper chaperone activity(GO:0016531) |
1.1 | 9.9 | GO:0019864 | IgG binding(GO:0019864) |
1.1 | 3.3 | GO:0042289 | MHC class II protein binding(GO:0042289) |
1.1 | 4.4 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
1.1 | 7.7 | GO:0042288 | MHC class I protein binding(GO:0042288) |
1.1 | 24.0 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
1.1 | 8.7 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
1.1 | 42.3 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
1.1 | 7.5 | GO:0016018 | cyclosporin A binding(GO:0016018) |
1.1 | 2.2 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
1.1 | 1.1 | GO:0045502 | dynein binding(GO:0045502) |
1.1 | 22.4 | GO:0042393 | histone binding(GO:0042393) |
1.1 | 7.4 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
1.1 | 2.1 | GO:0042605 | peptide antigen binding(GO:0042605) |
1.1 | 9.5 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
1.1 | 6.3 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
1.1 | 22.1 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
1.1 | 3.2 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
1.1 | 21.0 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
1.1 | 4.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
1.1 | 6.3 | GO:0046790 | virion binding(GO:0046790) |
1.0 | 6.3 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
1.0 | 5.2 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
1.0 | 13.5 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
1.0 | 5.2 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
1.0 | 14.5 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
1.0 | 14.5 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
1.0 | 4.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
1.0 | 7.1 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
1.0 | 1.0 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
1.0 | 2.0 | GO:0060590 | ATPase regulator activity(GO:0060590) |
1.0 | 3.0 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
1.0 | 2.0 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
1.0 | 1.0 | GO:0008242 | omega peptidase activity(GO:0008242) |
1.0 | 15.9 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
1.0 | 83.4 | GO:0051082 | unfolded protein binding(GO:0051082) |
1.0 | 2.0 | GO:0031628 | opioid receptor binding(GO:0031628) |
1.0 | 8.8 | GO:0048531 | beta-1,3-galactosyltransferase activity(GO:0048531) |
1.0 | 2.9 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.0 | 18.5 | GO:0030145 | manganese ion binding(GO:0030145) |
1.0 | 3.9 | GO:0048018 | receptor agonist activity(GO:0048018) |
1.0 | 2.9 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
1.0 | 10.7 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
1.0 | 3.9 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
1.0 | 6.8 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
1.0 | 98.6 | GO:0003702 | obsolete RNA polymerase II transcription factor activity(GO:0003702) |
1.0 | 3.9 | GO:0070097 | delta-catenin binding(GO:0070097) |
1.0 | 4.8 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
1.0 | 4.8 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
1.0 | 3.8 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
1.0 | 3.8 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
1.0 | 5.7 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
1.0 | 5.7 | GO:0010843 | obsolete promoter binding(GO:0010843) |
0.9 | 21.7 | GO:0016779 | nucleotidyltransferase activity(GO:0016779) |
0.9 | 0.9 | GO:0019205 | nucleobase-containing compound kinase activity(GO:0019205) |
0.9 | 3.8 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.9 | 0.9 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
0.9 | 4.7 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.9 | 3.7 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.9 | 9.3 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.9 | 6.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.9 | 3.7 | GO:0070513 | death domain binding(GO:0070513) |
0.9 | 1.9 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.9 | 6.5 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.9 | 1.8 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
0.9 | 30.3 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.9 | 2.8 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
0.9 | 9.2 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.9 | 5.5 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.9 | 56.6 | GO:0004386 | helicase activity(GO:0004386) |
0.9 | 24.6 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.9 | 0.9 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.9 | 28.1 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
0.9 | 3.6 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.9 | 11.8 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.9 | 1.8 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.9 | 8.1 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.9 | 6.3 | GO:0019894 | kinesin binding(GO:0019894) |
0.9 | 112.4 | GO:0016874 | ligase activity(GO:0016874) |
0.9 | 28.8 | GO:0008137 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.9 | 5.4 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.9 | 0.9 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.9 | 1.8 | GO:0001846 | opsonin binding(GO:0001846) |
0.9 | 7.2 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
0.9 | 413.6 | GO:0003723 | RNA binding(GO:0003723) |
0.9 | 6.2 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.9 | 12.5 | GO:0008378 | galactosyltransferase activity(GO:0008378) |
0.9 | 1.8 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.9 | 8.0 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.9 | 4.4 | GO:0019213 | deacetylase activity(GO:0019213) |
0.9 | 20.3 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.9 | 1.8 | GO:0008556 | potassium-transporting ATPase activity(GO:0008556) |
0.9 | 7.9 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.9 | 2.6 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.9 | 32.2 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.9 | 6.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.9 | 10.4 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.9 | 16.4 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
0.9 | 7.7 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.9 | 1.7 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.9 | 5.1 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.8 | 12.7 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.8 | 2.5 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.8 | 1.7 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.8 | 2.5 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
0.8 | 1.7 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.8 | 33.7 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.8 | 5.1 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.8 | 2.5 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.8 | 5.8 | GO:0001968 | fibronectin binding(GO:0001968) |
0.8 | 4.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.8 | 4.1 | GO:0005123 | death receptor binding(GO:0005123) |
0.8 | 22.2 | GO:0051287 | NAD binding(GO:0051287) |
0.8 | 0.8 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.8 | 3.3 | GO:0004308 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.8 | 36.8 | GO:0003700 | transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.8 | 7.3 | GO:1990782 | receptor tyrosine kinase binding(GO:0030971) protein tyrosine kinase binding(GO:1990782) |
0.8 | 2.4 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.8 | 2.4 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.8 | 8.0 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.8 | 3.2 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.8 | 0.8 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.8 | 7.2 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.8 | 1.6 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.8 | 1.6 | GO:0004803 | transposase activity(GO:0004803) |
0.8 | 19.9 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.8 | 1.6 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.8 | 1.6 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.8 | 0.8 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.8 | 4.0 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.8 | 13.4 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.8 | 3.2 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) |
0.8 | 2.4 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.8 | 3.2 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.8 | 3.9 | GO:0015923 | mannosidase activity(GO:0015923) |
0.8 | 2.4 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.8 | 3.9 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.8 | 1.6 | GO:0000977 | RNA polymerase II regulatory region sequence-specific DNA binding(GO:0000977) RNA polymerase II regulatory region DNA binding(GO:0001012) |
0.8 | 3.1 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.8 | 3.9 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.8 | 119.3 | GO:0003924 | GTPase activity(GO:0003924) |
0.8 | 220.8 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.8 | 3.1 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.8 | 6.1 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.8 | 2.3 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.8 | 0.8 | GO:0030172 | troponin C binding(GO:0030172) |
0.7 | 3.0 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.7 | 5.2 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.7 | 58.1 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.7 | 5.9 | GO:0042171 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.7 | 2.2 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.7 | 2.2 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.7 | 8.0 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.7 | 2.9 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.7 | 9.4 | GO:0015932 | nucleobase-containing compound transmembrane transporter activity(GO:0015932) |
0.7 | 2.2 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.7 | 1.4 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.7 | 5.1 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.7 | 17.3 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.7 | 2.2 | GO:0035258 | steroid hormone receptor binding(GO:0035258) |
0.7 | 1.4 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.7 | 2.1 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.7 | 14.1 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.7 | 14.1 | GO:0016769 | transferase activity, transferring nitrogenous groups(GO:0016769) |
0.7 | 2.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.7 | 9.8 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.7 | 2.1 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
0.7 | 11.9 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.7 | 10.5 | GO:0004527 | exonuclease activity(GO:0004527) |
0.7 | 7.0 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.7 | 2.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.7 | 0.7 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.7 | 4.8 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.7 | 77.6 | GO:0005525 | GTP binding(GO:0005525) |
0.7 | 5.5 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.7 | 2.1 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.7 | 1.4 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.7 | 2.0 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.7 | 56.4 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.7 | 2.7 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.7 | 1.4 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.7 | 14.2 | GO:0016675 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.7 | 4.7 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.7 | 58.3 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.7 | 0.7 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.7 | 1.3 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.7 | 0.7 | GO:0061733 | peptide-lysine-N-acetyltransferase activity(GO:0061733) |
0.7 | 3.9 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.7 | 19.7 | GO:0003690 | double-stranded DNA binding(GO:0003690) |
0.7 | 9.8 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.7 | 41.8 | GO:0003704 | obsolete specific RNA polymerase II transcription factor activity(GO:0003704) |
0.7 | 2.0 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.7 | 2.0 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.6 | 33.0 | GO:0004518 | nuclease activity(GO:0004518) |
0.6 | 1.9 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.6 | 1.9 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.6 | 1.9 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.6 | 0.6 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.6 | 3.2 | GO:0016566 | obsolete specific transcriptional repressor activity(GO:0016566) |
0.6 | 1.9 | GO:0009055 | electron carrier activity(GO:0009055) |
0.6 | 2.5 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.6 | 0.6 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.6 | 845.6 | GO:0003677 | DNA binding(GO:0003677) |
0.6 | 1.9 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.6 | 3.0 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.6 | 2.4 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.6 | 3.0 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.6 | 5.3 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.6 | 1.8 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.6 | 1.8 | GO:0070815 | procollagen-lysine 5-dioxygenase activity(GO:0008475) peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.6 | 14.5 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.6 | 6.4 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.6 | 8.1 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.6 | 1.7 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.6 | 32.6 | GO:0016614 | oxidoreductase activity, acting on CH-OH group of donors(GO:0016614) |
0.6 | 2.3 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.6 | 1.7 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.6 | 1.1 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.6 | 1.7 | GO:0016776 | phosphotransferase activity, phosphate group as acceptor(GO:0016776) |
0.6 | 1.7 | GO:0032451 | demethylase activity(GO:0032451) |
0.6 | 1.1 | GO:0031404 | chloride ion binding(GO:0031404) |
0.6 | 1.7 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.6 | 3.4 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.5 | 2.2 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.5 | 10.4 | GO:0016564 | obsolete transcription repressor activity(GO:0016564) |
0.5 | 1.6 | GO:0033691 | sialic acid binding(GO:0033691) |
0.5 | 12.4 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.5 | 3.2 | GO:0019829 | cation-transporting ATPase activity(GO:0019829) |
0.5 | 71.5 | GO:0003676 | nucleic acid binding(GO:0003676) |
0.5 | 8.0 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.5 | 2.1 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.5 | 2.1 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.5 | 3.7 | GO:0016410 | N-acyltransferase activity(GO:0016410) |
0.5 | 4.6 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.5 | 4.6 | GO:0005537 | mannose binding(GO:0005537) |
0.5 | 3.0 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.5 | 1.5 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.5 | 16.1 | GO:0031267 | small GTPase binding(GO:0031267) |
0.5 | 2.0 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.5 | 1.0 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.5 | 4.5 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.5 | 0.5 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.5 | 3.9 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.5 | 1.5 | GO:0016903 | oxidoreductase activity, acting on the aldehyde or oxo group of donors(GO:0016903) |
0.5 | 2.4 | GO:0016563 | obsolete transcription activator activity(GO:0016563) |
0.5 | 2.4 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.5 | 3.8 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.5 | 1.4 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.5 | 7.0 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.5 | 4.2 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.5 | 10.7 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.5 | 1.4 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.5 | 2.7 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.5 | 1.8 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
0.4 | 1.3 | GO:0019956 | chemokine binding(GO:0019956) |
0.4 | 2.7 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
0.4 | 1.3 | GO:0019863 | IgE binding(GO:0019863) |
0.4 | 2.2 | GO:0015355 | secondary active monocarboxylate transmembrane transporter activity(GO:0015355) |
0.4 | 204.0 | GO:0008270 | zinc ion binding(GO:0008270) |
0.4 | 0.4 | GO:0050662 | coenzyme binding(GO:0050662) |
0.4 | 1.7 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.4 | 1.3 | GO:0044877 | macromolecular complex binding(GO:0044877) |
0.4 | 7.3 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.4 | 1.3 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.4 | 2.5 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.4 | 4.2 | GO:0016835 | carbon-oxygen lyase activity(GO:0016835) |
0.4 | 7.5 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.4 | 21.2 | GO:0035091 | phosphatidylinositol binding(GO:0035091) |
0.4 | 80.5 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.4 | 2.4 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.4 | 6.4 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
0.4 | 1.6 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.4 | 11.2 | GO:0051015 | actin filament binding(GO:0051015) |
0.4 | 0.8 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.4 | 7.1 | GO:0008134 | transcription factor binding(GO:0008134) |
0.4 | 5.1 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.4 | 2.0 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.4 | 11.6 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.4 | 0.4 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.4 | 3.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.4 | 4.5 | GO:0019955 | cytokine binding(GO:0019955) |
0.4 | 0.4 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.4 | 1.9 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.4 | 3.7 | GO:0008047 | enzyme activator activity(GO:0008047) |
0.4 | 1.5 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.4 | 0.4 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.4 | 1.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.3 | 2.1 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.3 | 1.0 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.3 | 40.4 | GO:0003774 | motor activity(GO:0003774) |
0.3 | 1.4 | GO:0004064 | arylesterase activity(GO:0004064) |
0.3 | 0.3 | GO:0004437 | obsolete inositol or phosphatidylinositol phosphatase activity(GO:0004437) |
0.3 | 0.3 | GO:0043531 | ADP binding(GO:0043531) |
0.3 | 2.6 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.3 | 0.7 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.3 | 1.3 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.3 | 3.2 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.3 | 0.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.3 | 4.5 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.3 | 36.0 | GO:0016818 | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides(GO:0016818) |
0.3 | 0.3 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.3 | 0.6 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.3 | 0.3 | GO:0009975 | cyclase activity(GO:0009975) phosphorus-oxygen lyase activity(GO:0016849) |
0.3 | 3.3 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.3 | 6.3 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.3 | 1.2 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
0.3 | 1.2 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.3 | 1.1 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.3 | 3.7 | GO:0005319 | lipid transporter activity(GO:0005319) |
0.3 | 1.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.3 | 89.0 | GO:0016787 | hydrolase activity(GO:0016787) |
0.3 | 4.2 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.3 | 1.7 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.3 | 8.4 | GO:0005057 | receptor signaling protein activity(GO:0005057) |
0.3 | 0.3 | GO:0048185 | activin binding(GO:0048185) |
0.3 | 1.1 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.3 | 27.7 | GO:0001883 | purine nucleoside binding(GO:0001883) |
0.3 | 0.5 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.3 | 2.4 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.3 | 2.9 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.3 | 2.1 | GO:0043499 | obsolete eukaryotic cell surface binding(GO:0043499) |
0.3 | 7.0 | GO:0015631 | tubulin binding(GO:0015631) |
0.3 | 1.0 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.3 | 1.5 | GO:0015464 | acetylcholine receptor activity(GO:0015464) |
0.3 | 0.3 | GO:0016408 | C-acyltransferase activity(GO:0016408) |
0.3 | 5.4 | GO:0051213 | dioxygenase activity(GO:0051213) |
0.3 | 7.7 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.3 | 0.8 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.3 | 0.3 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.3 | 4.8 | GO:0016502 | G-protein coupled nucleotide receptor activity(GO:0001608) purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.2 | 3.5 | GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds(GO:0016810) |
0.2 | 3.2 | GO:0003823 | antigen binding(GO:0003823) |
0.2 | 1.7 | GO:0031419 | cobalamin binding(GO:0031419) |
0.2 | 1.2 | GO:0016798 | hydrolase activity, acting on glycosyl bonds(GO:0016798) |
0.2 | 1.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.2 | 0.2 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.2 | 0.2 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) lipoteichoic acid binding(GO:0070891) |
0.2 | 1.2 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.2 | 0.2 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.2 | 0.9 | GO:0008170 | N-methyltransferase activity(GO:0008170) |
0.2 | 0.7 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.2 | 526.5 | GO:0005515 | protein binding(GO:0005515) |
0.2 | 7.2 | GO:0000166 | nucleotide binding(GO:0000166) |
0.2 | 0.8 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.2 | 0.4 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.2 | 1.0 | GO:0008430 | selenium binding(GO:0008430) |
0.2 | 0.6 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.2 | 0.4 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.2 | 7.5 | GO:0016746 | transferase activity, transferring acyl groups(GO:0016746) |
0.2 | 0.8 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.2 | 1.2 | GO:0016773 | phosphotransferase activity, alcohol group as acceptor(GO:0016773) |
0.2 | 0.2 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.2 | 0.5 | GO:0005549 | odorant binding(GO:0005549) |
0.1 | 1.6 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.1 | 0.4 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.1 | 0.1 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.1 | 0.1 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.1 | 0.6 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 0.2 | GO:0015197 | peptide transporter activity(GO:0015197) |
0.1 | 0.2 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.1 | 0.3 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.1 | 0.3 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.6 | GO:0008757 | S-adenosylmethionine-dependent methyltransferase activity(GO:0008757) |
0.1 | 0.6 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.1 | 0.4 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.1 | 48.9 | GO:0005488 | binding(GO:0005488) |
0.1 | 0.2 | GO:0099589 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.0 | 0.1 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.1 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.0 | 0.3 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.0 | 6.8 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.0 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.0 | 5.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
3.3 | 36.7 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
3.0 | 42.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
3.0 | 41.7 | PID IL5 PATHWAY | IL5-mediated signaling events |
2.8 | 19.9 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
2.8 | 8.5 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
2.8 | 152.7 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
2.7 | 23.9 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
2.7 | 71.7 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
2.6 | 20.6 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
2.5 | 40.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
2.5 | 2.5 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
2.4 | 84.4 | PID BCR 5PATHWAY | BCR signaling pathway |
2.4 | 12.0 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
2.4 | 16.7 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
2.4 | 16.7 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
2.3 | 53.6 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
2.3 | 9.1 | PID S1P S1P4 PATHWAY | S1P4 pathway |
2.2 | 6.7 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
2.2 | 50.8 | PID IL2 1PATHWAY | IL2-mediated signaling events |
2.2 | 39.6 | PID IFNG PATHWAY | IFN-gamma pathway |
2.2 | 68.0 | PID FOXO PATHWAY | FoxO family signaling |
2.2 | 8.7 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
2.2 | 47.3 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
2.1 | 10.5 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
2.0 | 5.9 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
1.8 | 27.6 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
1.8 | 20.0 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
1.8 | 41.3 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
1.8 | 32.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
1.8 | 107.1 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
1.8 | 17.8 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
1.8 | 3.5 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
1.6 | 1.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
1.6 | 1.6 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
1.5 | 21.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
1.5 | 7.7 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
1.5 | 55.1 | PID MTOR 4PATHWAY | mTOR signaling pathway |
1.5 | 9.1 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
1.5 | 43.5 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
1.5 | 15.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
1.5 | 8.8 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
1.5 | 14.6 | PID S1P S1P1 PATHWAY | S1P1 pathway |
1.4 | 31.4 | PID BARD1 PATHWAY | BARD1 signaling events |
1.4 | 16.9 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
1.4 | 23.9 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
1.4 | 4.2 | ST GAQ PATHWAY | G alpha q Pathway |
1.4 | 2.8 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
1.4 | 52.4 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
1.4 | 39.4 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
1.3 | 18.6 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
1.3 | 11.9 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
1.3 | 11.6 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
1.3 | 3.9 | PID MYC PATHWAY | C-MYC pathway |
1.3 | 28.3 | PID P53 REGULATION PATHWAY | p53 pathway |
1.3 | 29.6 | PID ATR PATHWAY | ATR signaling pathway |
1.3 | 41.0 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
1.3 | 6.4 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
1.3 | 55.9 | PID P73PATHWAY | p73 transcription factor network |
1.3 | 8.9 | PID TRAIL PATHWAY | TRAIL signaling pathway |
1.3 | 22.7 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
1.3 | 1.3 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
1.2 | 69.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
1.2 | 6.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
1.2 | 11.1 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
1.2 | 27.1 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
1.2 | 2.4 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
1.2 | 3.6 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
1.2 | 21.1 | PID FANCONI PATHWAY | Fanconi anemia pathway |
1.2 | 7.0 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
1.2 | 19.7 | PID AURORA A PATHWAY | Aurora A signaling |
1.2 | 10.4 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
1.2 | 36.9 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
1.1 | 27.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
1.1 | 33.8 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
1.1 | 28.1 | PID PLK1 PATHWAY | PLK1 signaling events |
1.1 | 11.2 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
1.1 | 20.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
1.1 | 3.3 | PID ERBB4 PATHWAY | ErbB4 signaling events |
1.1 | 5.5 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
1.1 | 8.8 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
1.1 | 23.0 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
1.1 | 6.5 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
1.0 | 12.3 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
1.0 | 16.2 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
1.0 | 5.0 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
1.0 | 5.9 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
1.0 | 11.8 | PID IL12 2PATHWAY | IL12-mediated signaling events |
1.0 | 7.8 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
1.0 | 5.8 | ST G ALPHA S PATHWAY | G alpha s Pathway |
1.0 | 2.9 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
1.0 | 11.4 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.9 | 7.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.9 | 7.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.9 | 26.7 | PID CDC42 PATHWAY | CDC42 signaling events |
0.9 | 0.9 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.9 | 7.0 | PID ALK2 PATHWAY | ALK2 signaling events |
0.9 | 27.8 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.9 | 18.8 | PID E2F PATHWAY | E2F transcription factor network |
0.8 | 5.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.8 | 10.9 | PID ARF6 PATHWAY | Arf6 signaling events |
0.8 | 12.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.8 | 13.0 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.8 | 20.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.8 | 9.6 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.8 | 2.4 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.8 | 3.8 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.8 | 9.9 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.8 | 2.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.7 | 12.0 | PID INSULIN PATHWAY | Insulin Pathway |
0.7 | 8.1 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.7 | 8.0 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.7 | 12.1 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.7 | 19.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.7 | 13.7 | PID LKB1 PATHWAY | LKB1 signaling events |
0.7 | 10.8 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.7 | 9.2 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.6 | 7.1 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.6 | 5.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.6 | 1.9 | PID EPO PATHWAY | EPO signaling pathway |
0.6 | 35.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.6 | 1.8 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.6 | 11.5 | PID AURORA B PATHWAY | Aurora B signaling |
0.6 | 4.8 | PID REELIN PATHWAY | Reelin signaling pathway |
0.6 | 19.3 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.6 | 10.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.6 | 19.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.6 | 3.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.5 | 4.3 | PID ATM PATHWAY | ATM pathway |
0.5 | 0.5 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.5 | 1.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.5 | 6.7 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.5 | 1.5 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.5 | 3.9 | PID RHOA PATHWAY | RhoA signaling pathway |
0.4 | 4.8 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.4 | 8.7 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.4 | 6.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.4 | 1.2 | PID SHP2 PATHWAY | SHP2 signaling |
0.4 | 5.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.4 | 3.8 | PID BMP PATHWAY | BMP receptor signaling |
0.4 | 3.3 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.4 | 2.5 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.4 | 3.6 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.4 | 5.4 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.3 | 2.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.3 | 1.9 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.3 | 3.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.3 | 5.0 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.3 | 0.5 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.3 | 0.5 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.2 | 0.7 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.2 | 1.9 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.2 | 7.0 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.2 | 1.3 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.2 | 0.6 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.2 | 0.6 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 2.0 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.2 | 0.7 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.1 | 1.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.1 | 5.0 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 1.2 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 1.1 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 0.4 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 1.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 0.5 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.1 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.3 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.1 | PID IL23 PATHWAY | IL23-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.4 | 4.4 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
3.2 | 56.9 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
3.1 | 6.2 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
3.1 | 46.2 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
2.7 | 32.7 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
2.6 | 7.9 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
2.6 | 2.6 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
2.5 | 2.5 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
2.5 | 39.3 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
2.4 | 46.0 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
2.4 | 9.6 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
2.4 | 2.4 | REACTOME DOWNSTREAM SIGNALING OF ACTIVATED FGFR | Genes involved in Downstream signaling of activated FGFR |
2.4 | 35.3 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
2.3 | 2.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
2.3 | 2.3 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
2.3 | 53.2 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
2.3 | 23.1 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
2.3 | 2.3 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
2.3 | 2.3 | REACTOME SYNTHESIS OF DNA | Genes involved in Synthesis of DNA |
2.3 | 11.4 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
2.2 | 35.7 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
2.2 | 39.6 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
2.2 | 24.0 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
2.2 | 26.1 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
2.2 | 95.3 | REACTOME TCR SIGNALING | Genes involved in TCR signaling |
2.1 | 21.5 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
2.1 | 19.0 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
2.1 | 33.1 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
2.0 | 2.0 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
2.0 | 36.4 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
2.0 | 48.3 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
2.0 | 6.0 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
2.0 | 11.9 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
2.0 | 23.5 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
1.9 | 23.1 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
1.9 | 51.4 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
1.8 | 58.6 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
1.8 | 7.3 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
1.8 | 16.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
1.8 | 21.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
1.8 | 35.6 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
1.8 | 14.0 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
1.7 | 13.9 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
1.7 | 26.0 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
1.7 | 24.2 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
1.7 | 19.0 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
1.7 | 6.9 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
1.7 | 6.9 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
1.7 | 47.9 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
1.7 | 6.8 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
1.7 | 11.9 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
1.7 | 1.7 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
1.7 | 50.3 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
1.7 | 23.4 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
1.7 | 28.2 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
1.6 | 27.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
1.6 | 30.8 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
1.6 | 4.8 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
1.6 | 3.2 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
1.6 | 1.6 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
1.6 | 30.2 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
1.6 | 14.3 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
1.6 | 22.1 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
1.6 | 9.4 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
1.6 | 12.5 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
1.6 | 23.4 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
1.6 | 12.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
1.5 | 3.1 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
1.5 | 1.5 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
1.5 | 24.6 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
1.5 | 15.3 | REACTOME METABOLISM OF MRNA | Genes involved in Metabolism of mRNA |
1.5 | 6.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
1.5 | 31.9 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
1.5 | 16.7 | REACTOME ASSEMBLY OF THE PRE REPLICATIVE COMPLEX | Genes involved in Assembly of the pre-replicative complex |
1.5 | 25.7 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
1.5 | 12.1 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
1.5 | 13.6 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
1.5 | 18.0 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
1.5 | 6.0 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
1.5 | 70.4 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
1.5 | 123.1 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
1.4 | 15.7 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
1.4 | 8.6 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
1.4 | 8.6 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
1.4 | 12.8 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
1.4 | 14.1 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
1.4 | 2.8 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
1.4 | 16.8 | REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C | Genes involved in Autodegradation of Cdh1 by Cdh1:APC/C |
1.4 | 29.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
1.4 | 2.8 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
1.4 | 16.4 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
1.3 | 13.3 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
1.3 | 22.6 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
1.3 | 13.3 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
1.3 | 2.6 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
1.3 | 17.1 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
1.3 | 30.1 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
1.3 | 2.6 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
1.3 | 2.6 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
1.3 | 20.8 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
1.3 | 23.3 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
1.3 | 11.6 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
1.3 | 43.8 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
1.3 | 39.5 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
1.3 | 2.5 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
1.3 | 145.4 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
1.3 | 1.3 | REACTOME SIGNALING BY TGF BETA RECEPTOR COMPLEX | Genes involved in Signaling by TGF-beta Receptor Complex |
1.2 | 44.7 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
1.2 | 19.8 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
1.2 | 18.5 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
1.2 | 8.5 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
1.2 | 9.7 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
1.2 | 4.8 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
1.2 | 20.3 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
1.2 | 5.9 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
1.2 | 3.5 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
1.2 | 10.5 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
1.2 | 4.7 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
1.2 | 53.4 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
1.2 | 16.2 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
1.1 | 3.4 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
1.1 | 18.1 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
1.1 | 7.8 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
1.1 | 33.4 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
1.1 | 14.3 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
1.1 | 1.1 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
1.1 | 2.2 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
1.1 | 13.0 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
1.1 | 14.1 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
1.1 | 23.7 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
1.1 | 49.5 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
1.1 | 15.9 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
1.1 | 49.9 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
1.1 | 11.6 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
1.1 | 25.2 | REACTOME KINESINS | Genes involved in Kinesins |
1.0 | 13.6 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
1.0 | 59.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
1.0 | 13.5 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
1.0 | 18.7 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
1.0 | 87.2 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
1.0 | 13.4 | REACTOME MYD88 MAL CASCADE INITIATED ON PLASMA MEMBRANE | Genes involved in MyD88:Mal cascade initiated on plasma membrane |
1.0 | 6.2 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
1.0 | 8.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
1.0 | 21.5 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
1.0 | 4.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
1.0 | 18.0 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
1.0 | 52.0 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
1.0 | 2.0 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
1.0 | 129.4 | REACTOME TRANSLATION | Genes involved in Translation |
1.0 | 15.8 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
1.0 | 3.9 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
1.0 | 27.1 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
1.0 | 21.1 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
1.0 | 6.7 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.9 | 1.9 | REACTOME POST NMDA RECEPTOR ACTIVATION EVENTS | Genes involved in Post NMDA receptor activation events |
0.9 | 18.8 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.9 | 1.9 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.9 | 7.5 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.9 | 8.2 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.9 | 26.7 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.9 | 17.7 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.9 | 0.9 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.9 | 0.9 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.9 | 14.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.9 | 14.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.9 | 11.2 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.9 | 11.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.9 | 12.0 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.9 | 12.0 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.9 | 1.7 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.9 | 6.8 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.8 | 18.6 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.8 | 5.9 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.8 | 40.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.8 | 1.7 | REACTOME NFKB AND MAP KINASES ACTIVATION MEDIATED BY TLR4 SIGNALING REPERTOIRE | Genes involved in NFkB and MAP kinases activation mediated by TLR4 signaling repertoire |
0.8 | 5.8 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.8 | 10.6 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.8 | 10.6 | REACTOME TCA CYCLE AND RESPIRATORY ELECTRON TRANSPORT | Genes involved in The citric acid (TCA) cycle and respiratory electron transport |
0.8 | 6.5 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.8 | 45.5 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.8 | 4.8 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.8 | 12.7 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.8 | 18.2 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.8 | 4.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.7 | 20.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.7 | 2.2 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.7 | 1.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.7 | 15.6 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.7 | 15.5 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.7 | 22.3 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.7 | 5.5 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.7 | 4.7 | REACTOME TOLL RECEPTOR CASCADES | Genes involved in Toll Receptor Cascades |
0.7 | 29.2 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.7 | 5.3 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.7 | 5.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.6 | 21.4 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.6 | 1.9 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.6 | 12.9 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.6 | 1.9 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.6 | 8.3 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.6 | 20.4 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.6 | 14.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.6 | 4.4 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.6 | 14.3 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.6 | 2.4 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.6 | 5.4 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.6 | 4.7 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.6 | 18.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.6 | 11.7 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.5 | 6.6 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.5 | 0.5 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.5 | 0.5 | REACTOME APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
0.5 | 9.1 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.5 | 2.1 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.5 | 6.8 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.5 | 4.6 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.5 | 1.0 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.5 | 2.5 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.5 | 1.0 | REACTOME SIGNALING BY NOTCH | Genes involved in Signaling by NOTCH |
0.5 | 4.4 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.5 | 17.9 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.5 | 7.1 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.5 | 117.5 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.5 | 0.9 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |
0.5 | 6.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.4 | 0.9 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.4 | 3.9 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.4 | 9.9 | REACTOME PI3K CASCADE | Genes involved in PI3K Cascade |
0.4 | 27.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.4 | 0.9 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.4 | 11.4 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.4 | 4.2 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.4 | 5.2 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.4 | 4.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.4 | 3.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.3 | 4.0 | REACTOME MEIOSIS | Genes involved in Meiosis |
0.3 | 4.5 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.3 | 1.5 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.3 | 3.0 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.3 | 2.4 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.3 | 13.2 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.3 | 0.3 | REACTOME REGULATION OF MITOTIC CELL CYCLE | Genes involved in Regulation of mitotic cell cycle |
0.3 | 0.9 | REACTOME INTEGRATION OF ENERGY METABOLISM | Genes involved in Integration of energy metabolism |
0.3 | 1.7 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.3 | 3.6 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.3 | 3.5 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.3 | 7.0 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.3 | 6.5 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.3 | 1.5 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.3 | 3.0 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.3 | 4.6 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.2 | 2.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.2 | 3.5 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.2 | 0.4 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.2 | 18.6 | REACTOME METABOLISM OF CARBOHYDRATES | Genes involved in Metabolism of carbohydrates |
0.2 | 5.2 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.2 | 1.1 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.2 | 1.8 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.2 | 9.6 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.2 | 1.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 3.8 | REACTOME METABOLISM OF STEROID HORMONES AND VITAMINS A AND D | Genes involved in Metabolism of steroid hormones and vitamins A and D |
0.2 | 0.9 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.1 | 0.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 1.7 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.1 | 0.5 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.1 | 6.3 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 2.7 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.1 | 1.3 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 0.7 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.1 | 0.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 0.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 0.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 1.6 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.1 | 0.3 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.1 | 0.4 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
0.1 | 0.2 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.1 | 3.3 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 0.4 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.0 | REACTOME CYTOKINE SIGNALING IN IMMUNE SYSTEM | Genes involved in Cytokine Signaling in Immune system |
0.0 | 0.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.8 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 5.7 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.1 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |